<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">63453</article-id><article-id pub-id-type="doi">10.7554/eLife.63453</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>The mitochondrial permeability transition pore activates the mitochondrial unfolded protein response and promotes aging</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-196850"><name><surname>Angeli</surname><given-names>Suzanne</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6229-9648</contrib-id><email>sangeli@buckinstitute.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213225"><name><surname>Foulger</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-198919"><name><surname>Chamoli</surname><given-names>Manish</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0339-7894</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213226"><name><surname>Peiris</surname><given-names>Tanuja Harshani</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213227"><name><surname>Gerencser</surname><given-names>Akos</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213229"><name><surname>Shahmirzadi</surname><given-names>Azar Asadi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-57639"><name><surname>Andersen</surname><given-names>Julie</given-names></name><email>jandersen@buckinstitute.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-56587"><name><surname>Lithgow</surname><given-names>Gordon</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8953-3043</contrib-id><email>glithgow@buckinstitute.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Buck Institute for Research on Aging</institution><addr-line><named-content content-type="city">Novato</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>USC Leonard Davis School of Gerontology, University of Southern California</institution><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Lee</surname><given-names>Siu Sylvia</given-names></name><role>Reviewing Editor</role><aff><institution>Cornell University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Tyler</surname><given-names>Jessica K</given-names></name><role>Senior Editor</role><aff><institution>Weill Cornell Medicine</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>01</day><month>09</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e63453</elocation-id><history><date date-type="received" iso-8601-date="2020-09-28"><day>28</day><month>09</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-08-15"><day>15</day><month>08</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2020-11-04"><day>04</day><month>11</month><year>2020</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2020.11.03.366815"/></event></pub-history><permissions><copyright-statement>© 2021, Angeli et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Angeli et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-63453-v1.pdf"/><abstract><p>Mitochondrial activity determines aging rate and the onset of chronic diseases. The mitochondrial permeability transition pore (mPTP) is a pathological pore in the inner mitochondrial membrane thought to be composed of the F-ATP synthase (complex V). OSCP, a subunit of F-ATP synthase, helps protect against mPTP formation. How the destabilization of OSCP may contribute to aging, however, is unclear. We have found that loss OSCP in the nematode <italic>Caenorhabditis elegans</italic> initiates the mPTP and shortens lifespan specifically during adulthood, in part via initiation of the mitochondrial unfolded protein response (UPR<sup>mt</sup>). Pharmacological or genetic inhibition of the mPTP inhibits the UPR<sup>mt</sup> and restores normal lifespan. Loss of the putative pore-forming component of F-ATP synthase extends adult lifespan, suggesting that the mPTP normally promotes aging. Our findings reveal how an mPTP/UPR<sup>mt</sup> nexus may contribute to aging and age-related diseases and how inhibition of the UPR<sup>mt</sup> may be protective under certain conditions.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>mitochondrial unfolded protein response</kwd><kwd>mitochondrial permeability transition pore</kwd><kwd>oscp/atp-3</kwd><kwd>c-subunit</kwd><kwd>aging</kwd><kwd>F-ATP synthase</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>C. elegans</italic></kwd></kwd-group><funding-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000049</institution-id><institution>National Institute on Aging</institution></institution-wrap></funding-source><award-id>R01AG029631</award-id><principal-award-recipient><name><surname>Lithgow</surname><given-names>Gordon</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001167</institution-id><institution>Larry L. Hillblom Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Chamoli</surname><given-names>Manish</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000049</institution-id><institution>National Institute on Aging</institution></institution-wrap></funding-source><award-id>RF1A057358</award-id><principal-award-recipient><name><surname>Lithgow</surname><given-names>Gordon</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Loss of the F-ATP synthase c-subunit inhibits a pathological mitochondrial permeability transition pore that is coupled to a maladaptive mitochondrial unfolded protein response while also extending lifespan.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>As mitochondrial function declines with age, the frequency of the mitochondrial permeability transition pore (mPTP) increases (<xref ref-type="bibr" rid="bib68">Rottenberg and Hoek, 2017</xref>). The mPTP is central to early-stage pathologies associated with several age-related diseases, including Alzheimer’s disease (AD) and Parkinson’s disease (PD) and late-stage pathologies of ischemia-reperfusion injuries including heart attack and stroke (<xref ref-type="bibr" rid="bib62">Ong et al., 2015</xref>; <xref ref-type="bibr" rid="bib63">Panel et al., 2018</xref>). The mPTP is a pathological channel that forms in the inner mitochondrial membrane in response to excessive cytosolic Ca<sup>2+</sup> or high ROS conditions. Sustained opening of the mPTP leads to outer mitochondrial membrane rupture, release of Ca<sup>2+</sup> into the cytosol, and cell death (<xref ref-type="bibr" rid="bib14">Bernardi and Di Lisa, 2015</xref>). Cyclosporin A (CsA), a well-characterized mPTP inhibitor, inhibits the mPTP by binding and sequestering cyclophilin D, a mitochondrially localized peptidyl prolyl isomerase that helps catalyze pore formation (<xref ref-type="bibr" rid="bib9">Basso et al., 2005</xref>; <xref ref-type="bibr" rid="bib57">Nakagawa et al., 2005</xref>). Genetic inhibition of cyclophilin D protects against mPTP formation (<xref ref-type="bibr" rid="bib7">Baines et al., 2005</xref>), and CsA has been shown to extend lifespan in <italic>Caenorhabditis elegans</italic> (<xref ref-type="bibr" rid="bib75">Ye et al., 2014</xref>). Thus, the mPTP appears to be an important modulator of healthspan and lifespan.</p><p>The identification of the proteins that make up the mPTP is controversial. Recent models have moved away from the models that invoked the voltage-dependent anion channel (VDAC), mitochondrial phosphate carrier (PiC), and translocator protein (TPSO) due to genetic ablation studies showing that the mPTP can still occur in their absence (<xref ref-type="bibr" rid="bib43">Kwong and Molkentin, 2015</xref>). Due to a multitude of recent studies, many experts in the field of mPTP have pointed to the F-ATP synthase (complex V) as the most probable inner mitochondrial pore candidate (<xref ref-type="bibr" rid="bib16">Bonora et al., 2017</xref>; <xref ref-type="bibr" rid="bib18">Carraro et al., 2019</xref>; <xref ref-type="bibr" rid="bib52">Mnatsakanyan and Jonas, 2020</xref>). F-ATP synthase is able to bind cyclophilin D and form Ca<sup>2+</sup> currents (<xref ref-type="bibr" rid="bib14">Bernardi and Di Lisa, 2015</xref>; <xref ref-type="bibr" rid="bib52">Mnatsakanyan and Jonas, 2020</xref>). Some models posit that dimeric forms of F-ATP synthase open to form a pore while other models have suggested that the pore occurs via the membrane-bound proton-driving c-ring rotor (<xref ref-type="bibr" rid="bib1">Alavian et al., 2014</xref>; <xref ref-type="bibr" rid="bib6">Azarashvili et al., 2014</xref>; <xref ref-type="bibr" rid="bib15">Bonora et al., 2013</xref>; <xref ref-type="bibr" rid="bib16">Bonora et al., 2017</xref>; <xref ref-type="bibr" rid="bib29">Giorgio et al., 2013</xref>; <xref ref-type="bibr" rid="bib51">Mnatsakanyan et al., 2019</xref>; <xref ref-type="bibr" rid="bib60">Neginskaya et al., 2019</xref>; <xref ref-type="bibr" rid="bib74">Urbani et al., 2019</xref>). Despite mounting evidence supporting F-ATP synthase as the pore-forming component of the mPTP, systematic deletion of nearly every subunit of F-ATP synthase in a cell model showed that a pore is still capable of forming (<xref ref-type="bibr" rid="bib20">Carroll et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">He et al., 2017a</xref>; <xref ref-type="bibr" rid="bib35">He et al., 2017b</xref>), leading some groups to suggest that in the absence of an intact F-ATP synthase, smaller low-conductance CsA-dependent pores distinct from the mPTP form (<xref ref-type="bibr" rid="bib60">Neginskaya et al., 2019</xref>). Other groups have proposed that the mPTP can be mediated by adenine nucleotide transporter (ANT), which exchanges ADP and ATP across the IMM. Genetic inhibition of ANTs helps prevent pore formation (<xref ref-type="bibr" rid="bib40">Karch et al., 2019</xref>), and the ‘multi-pore model’ posits that the mPTP can be mediated by ANT, as well as a cyclophilin D binding structure, such as F-ATP synthase, which would explain why deletion of putative pore components may still yield pore formation (<xref ref-type="bibr" rid="bib18">Carraro et al., 2019</xref>; <xref ref-type="bibr" rid="bib40">Karch et al., 2019</xref>; <xref ref-type="bibr" rid="bib19">Carrer et al., 2021</xref>).</p><p>ATP5O, also known as oligomycin sensitivity-conferring protein (OSCP), a subunit of the F-ATP synthase that regulates ATPase rotational activity to provide efficient ATP production (<xref ref-type="bibr" rid="bib56">Murphy et al., 2019</xref>), has emerged as an important regulator of the mPTP. OSCP confers protection against the mPTP under low pH conditions and loss of OSCP increases propensity for mPTP formation <italic>in vitro</italic> (<xref ref-type="bibr" rid="bib5">Antoniel et al., 2018</xref>; <xref ref-type="bibr" rid="bib29">Giorgio et al., 2013</xref>). In mice, levels of OSCP decrease with normal aging (<xref ref-type="bibr" rid="bib27">Gauba et al., 2017</xref>). In mouse models of AD, OSCP binds to amyloid beta (Aβ) and the propensity for mPTP formation increases, suggesting that the destabilization of OSCP contributes to mPTP formation (<xref ref-type="bibr" rid="bib11">Beck et al., 2016b</xref>). Conversely, OSCP overexpression protects from mPTP initiation in AD and cardiac dysfunction models (<xref ref-type="bibr" rid="bib11">Beck et al., 2016b</xref>; <xref ref-type="bibr" rid="bib32">Guo et al., 2020</xref>). Thus, OSCP appears to be an important regulator of aging and disease progression, possibly via its ability to modulate mPTP formation.</p><p>Under mitochondrial stress, the mitochondria attempt to repair the damage, recycle damaged mitochondria, or, under deleterious circumstances, initiate cell death. Similar to the endoplasmic reticulum unfolded protein response (UPR<sup>ER</sup>) and the cytoplasmic heat shock response (HSR), the mitochondrial unfolded protein response (UPR<sup>mt</sup>) is capable of initiating a broad-range transcriptional response that, among other functions, aids in the refolding of mitochondrial matrix proteins (<xref ref-type="bibr" rid="bib58">Naresh and Haynes, 2019</xref>). Recent studies also show that a loss of mitochondrial membrane potential (MMP) correlates with activation of the UPR<sup>mt</sup>, and disruption of mitochondrial processes other than protein misfolding, such as those involved in TCA cycle and lipid catabolism, also induce the UPR<sup>mt</sup> (<xref ref-type="bibr" rid="bib67">Rolland et al., 2019</xref>). UPR<sup>mt</sup> activation is associated with longevity and improvement in neurodegenerative models (<xref ref-type="bibr" rid="bib24">Durieux et al., 2011</xref>; <xref ref-type="bibr" rid="bib37">Houtkooper et al., 2013</xref>; <xref ref-type="bibr" rid="bib42">Kim et al., 2016</xref>; <xref ref-type="bibr" rid="bib50">Merkwirth et al., 2016</xref>; <xref ref-type="bibr" rid="bib71">Sorrentino et al., 2017</xref>; <xref ref-type="bibr" rid="bib73">Tian et al., 2016</xref>), but it has also conversely been shown to increase neurodegeneration, propagate mtDNA mutations, and exacerbate ischemic conditions (<xref ref-type="bibr" rid="bib46">Lin et al., 2016</xref>; <xref ref-type="bibr" rid="bib49">Martinez et al., 2017</xref>; <xref ref-type="bibr" rid="bib77">Yung et al., 2019</xref>), underscoring its complexity. If left unmitigated, UPRs can initiate cell death (<xref ref-type="bibr" rid="bib38">Iurlaro and Muñoz-Pinedo, 2016</xref>; <xref ref-type="bibr" rid="bib55">Münch and Harper, 2016</xref>). Thus, the context or cellular environment are important determinants of whether UPR<sup>mt</sup> induction results in beneficial or detrimental effects.</p><p>In <italic>C. elegans</italic>, mild mitochondrial perturbations early in life can extend lifespan. Loss of OSCP/<italic>atp-3</italic> has previously been shown to extend lifespan when initiated during larval development (<xref ref-type="bibr" rid="bib23">Dillin et al., 2002</xref>; <xref ref-type="bibr" rid="bib66">Rea et al., 2007</xref>). In contrast, here, we have determined that loss of OSCP/<italic>atp-3</italic> during adulthood leads to initiation of the mPTP, the UPR<sup>mt</sup>, and a shortened lifespan. Surprisingly, <italic>atfs-1</italic>, the UPR<sup>mt</sup> master transcription factor (<xref ref-type="bibr" rid="bib33">Haynes et al., 2010</xref>; <xref ref-type="bibr" rid="bib59">Nargund et al., 2012</xref>), helps drive the reduction of lifespan, suggesting that the UPR<sup>mt</sup> program can promote aging during adulthood. The adult UPR<sup>mt</sup> is responsive to mPTP regulators, including the immunosuppressive drug, CsA, as well as a mitochondrially localized cyclophilin and ANTs, pointing to a previously undiscovered coordination between the UPR<sup>mt</sup> and the mPTP. We find that the proton-driving rotor subunit as well as subunits important for dimerization of the F-ATP synthase are essential for transducing the adult UPR<sup>mt</sup>. Loss of these subunits as well as pharmacological CsA treatment restores lifespan due to loss of OSCP/<italic>atp-3</italic>. These results are consistent with current models that posit that the F-ATP synthase forms the mPTP (<xref ref-type="bibr" rid="bib14">Bernardi and Di Lisa, 2015</xref>). Overall, our findings point to a model in which loss of OSCP/<italic>atp-3</italic> in adults induces mPTP formation with subsequent activation of the UPR<sup>mt</sup>. Understanding the relationship between these two mitochondrial processes will further our understanding of aging as well as disparate age-related disorders, including neurodegenerative diseases, cancer, heart attack, and stroke.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Loss of OSCP/<italic>atp-3</italic> during adulthood induces mPTP characteristics </title><p>The opening of the mPTP is characterized by a loss of MMP as well as an increase in cytosolic Ca<sup>2+</sup> and responsiveness to the mPTP inhibitor, CsA. We observed that a reduction in the abundance of OSCP/<italic>atp-3</italic> by RNA interference (RNAi) during adulthood caused a loss of MMP as measured by the mitochondrial dye, tetramethylrhodamine methyl ester (TMRM), while RNAi of other OXPHOS subunits from complex I, IV, and V had no effect on the MMP (<xref ref-type="fig" rid="fig1">Figure 1A, B</xref>). RNAi of OSCP/<italic>atp-3</italic> during adulthood also caused an increase in cytosolic Ca<sup>2+</sup> as measured by the intestinal FRET-based Ca<sup>2+</sup> reporter, KWN190, while RNAi of subunits from complex IV and complex V did not (<xref ref-type="fig" rid="fig1">Figure 1D, E</xref>). CsA rescued the loss of MMP and suppressed the rise of cytosolic Ca<sup>2+</sup> caused by RNAi of OSCP/<italic>atp-3</italic> during adulthood (<xref ref-type="fig" rid="fig1">Figure 1C, F</xref>). Loss of OSCP/<italic>atp-3</italic> also induced mitochondrial swelling and fragmentation compared to control, which was rescued by CsA (<xref ref-type="fig" rid="fig1">Figure 1G–J</xref>). To determine if a loss of MMP during adulthood was sufficient to recapitulate mPTP characteristics, we tested the effects of FCCP, a potent mitochondrial uncoupler. FCCP induced a loss of MMP when administered during adulthood, but did not lead to an increase in cytosolic Ca<sup>2+</sup> (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A, B</xref>), suggesting that a loss in MMP is not sufficient to recapitulate mPTP characteristics. Similarly, loss of OSCP/<italic>atp-3</italic> RNAi during development, which leads to a loss of MMP, did not lead to an increase in cytosolic Ca<sup>2+</sup> (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C, D</xref>), demonstrating that phenotypes that result from a loss of OSCP/<italic>atp-3</italic> are distinct during adulthood versus development. Overall, these results suggest that loss of OSCP/<italic>atp-3</italic> during adulthood uniquely induces the mPTP in <italic>C. elegans</italic>.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Loss of OSCP/<italic>atp-3</italic> during adulthood selectively recapitulates mitochondrial permeability transition pore (mPTP)-like characteristics.</title><p>(<bold>A</bold>) Photomicrographs of mitochondrial membrane potential (MMP) as measured by tetramethylrhodamine methyl ester (TMRM) after RNA interference (RNAi) of OXPHOS subunits. RNAi and TMRM were administered for 48 hr beginning at young adulthood. Representative micrographs shown. (<bold>B</bold>) Quantification of TMRM intensity from (<bold>A</bold>). Data are the mean ± SEM of ≤ 15 animals combined from three biological experiments. **p≤0.01 by Student’s <italic>t</italic>-test. I, IV, and V correspond to OXPHOS complexes. a.u.: arbitrary units. (<bold>C</bold>) Quantification of MMP after RNAi of OSCP/<italic>atp-3</italic> and treatment with cyclosporin A (CsA: 15 μM). RNAi and CsA were administered beginning at young adulthood for 24 hr. Data are the mean ± SEM of ≤ 15 animals combined from three biological experiments. *p≤0.05, **p≤0.01 by Student’s <italic>t</italic>-test. (<bold>D</bold>) Confocal micrograph of intestinal cytosolic Ca<sup>2+</sup> as measured by the FRET-based calcium indicator protein D3cpv/cameleon after OSCP/<italic>atp-3</italic> RNAi. RNAi was administered for 48 hr beginning at young adulthood. Representative micrograph shown. (<bold>E</bold>) Quantification of FRET YFP/CFP ratio after RNAi of OXPHOS subunits. RNAi was administered for 48 hr beginning at young adulthood. Data are the mean ± SEM of ≤ 15 animals combined from three biological experiments. **p≤0.01 by Student’s <italic>t</italic>-test. (<bold>F</bold>) Quantification of FRET YFP/CFP ratio after RNAi of OSCP/<italic>atp-3</italic> and treatment with CsA (15 μM). RNAi and CsA were administered beginning at young adulthood for 48 hr. Data are the mean ± SEM of ≤ 15 animals combined from three biological experiments. **p≤0.01 by Student’s <italic>t</italic>-test. (<bold>G–J</bold>) Confocal micrographs of intestinal mitochondria labeled with GFP (p<italic>ges-1</italic>::GFP<sup>mt</sup>) in young adults. RNAi and CsA were administered for 48 hr beginning at young adulthood, then worms were removed from the RNAi and CsA and aged until day 7 of adulthood followed by collection for microscopy. Top panels: fluorescent channel; bottom panels: rendering of individual mitochondria. CV: control vector; Ctrl: solvent control; CsA: 15 μM. See Materials and methods for details on rendering.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63453-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Loss of OSCP/<italic>atp-3</italic> RNAi during adulthood uniquely causes a loss in membrane potential and a rise in cytosolic calcium.</title><p>(<bold>A</bold>) FCCP, the mitochondrial uncoupler, significantly induces a loss in mitochondrial membrane potential (MMP). FCCP was administered for 24–48 hr beginning at young adulthood (YA). Data are the mean ± SEM of ≤ 15 animals from three biological experiments. ***p≤0.0001 by Student’s <italic>t</italic>-test. (<bold>B</bold>) FCCP does not affect significantly alter cytosolic Ca<sup>2+</sup> using the FRET-based calcium indicator protein D3cpv/cameleon. Data are the mean ± SEM of ≤ 15 animals from three biological experiments. (<bold>C</bold>) Developmental RNAi of OSCP/<italic>atp-3</italic> induces a loss in MMP. RNAi was administered beginning from eggs for 72 hr. Tetramethylrhodamine methyl ester (TMRM) was spotted on seeded plates. ***p≤0.0001 by Student’s <italic>t</italic>-test. (<bold>D</bold>) Developmental RNAi of OSCP/<italic>atp-3</italic> does not significantly alter cytosolic Ca<sup>2+</sup> using the FRET-based calcium indicator protein D3cpv/cameleon compared to post-developmental RNAi. Developmental RNAi was administered beginning from eggs for 72 hr. Post-developmental RNAi was administered for 48 hr beginning from YA. **p≤0.01 by Student’s <italic>t</italic>-test. (<bold>E</bold>) qPCR from N2 worms after RNAi of subunits from complex I, IV, and V. RNAi was administered for 48 hr beginning at YA. Data are the mean ± SD ≤ 150 animals combined from two experiments. **p≤0.01, ***p≤0.0001 by Student’s <italic>t</italic>-test. (<bold>F</bold>) Immunoblots from N2 worms after RNAi of subunits from complex I and V. RNAi was administered for 48 hr beginning at YA. Representative immunoblots from two biological experiments. Actin was used as a loading control. (<bold>G</bold>) Fragments per kilobase of transcript per million (FPKM) expression values of various OXPHOS subunits collected at L1 larval stage or YA from <ext-link ext-link-type="uri" xlink:href="https://wormbase.org/#012-34-5">wormbase.org</ext-link>.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Source data for immunoblot (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>).</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-63453-fig1-figsupp1-data1-v1.jpg.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Source data for immunoblot (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>).</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-63453-fig1-figsupp1-data2-v1.jpg.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata3"><label>Figure 1—figure supplement 1—source data 3.</label><caption><title>Source data for immunoblot (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>).</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-63453-fig1-figsupp1-data3-v1.jpg.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63453-fig1-figsupp1-v1.tif"/></fig></fig-group><p>To determine if RNA expression levels of OSCP/<italic>atp-3</italic> may be higher during adulthood compared to other OXPHOS subunits, which would sensitize it to RNAi, we examined available RNAseq data from <ext-link ext-link-type="uri" xlink:href="https://wormbase.org/#012-34-5">wormbase.org</ext-link>. Fragments per kilobase of transcript per million (FPKM) expression values of various OXPHOS subunits collected at young adulthood (YA) showed that OSCP/<italic>atp-3</italic> did not display higher expression compared to other subunits, and that its expression during larval stages (L1) and YA was also comparable (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>). To verify that the lack of a phenotypes from the other OXPHOS subunits was not due to inefficient RNAi, we checked for RNAi efficiency via qPCR. We observed efficient mRNA reduction for all tested subunits, suggesting that the RNAi was effective (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). We also examined protein levels for subunits in which antibodies were available and observed that RNAi of the complex I subunit NUO-2 and complex V subunits ATP-1 and ATP-2 resulted in significant knockdown of protein levels (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>, <xref ref-type="supplementary-material" rid="fig1s1sdata1">Figure 1—figure supplement 1—source data 1</xref>–<xref ref-type="supplementary-material" rid="fig1s1sdata3">3</xref>). These findings support our conclusions that loss of OSCP/<italic>atp-3</italic> uniquely recapitulates mPTP characteristics during adulthood.</p></sec><sec id="s2-2"><title>Loss of OSCP/<italic>atp-3</italic> during adulthood induces a unique UPR<sup>mt</sup> </title><p>A recent study showed that a loss of MMP in <italic>C. elegans</italic> during development is associated with induction of the UPR<sup>mt</sup> (<xref ref-type="bibr" rid="bib67">Rolland et al., 2019</xref>). To determine if RNAi of OSCP/<italic>atp-3</italic> selectively induces the UPR<sup>mt</sup> during adulthood due to its observed loss in MMP (<xref ref-type="fig" rid="fig1">Figure 1A, B</xref>), we utilized a GFP reporter under the promoter of the UPR<sup>mt</sup> chaperone, <italic>hsp-6</italic> (p<italic>hsp-6</italic>::GFP) (<xref ref-type="bibr" rid="bib76">Yoneda et al., 2004</xref>), and compared it to select representative OXPHOS genes encoding complex I, III, IV, and V subunits. RNAi of OXPHOS subunits induced little to no UPR<sup>mt</sup> if initiated after the last larval stage (L4), which we termed the post-developmental UPR<sup>mt</sup> (pdvUPR<sup>mt</sup>) (<xref ref-type="fig" rid="fig2">Figure 2A,B</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). The exception was RNAi of OSCP/<italic>atp-3</italic>, which induced a robust UPR<sup>mt</sup> in young adults (<xref ref-type="fig" rid="fig2">Figure 2A, B</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>), the timing of which corresponded with the loss in MMP (<xref ref-type="fig" rid="fig1">Figure 1A, B</xref>). In contrast, RNAi of all the same genes induced a robust UPR<sup>mt</sup> if initiated during the early larval stages (L1, L2, and L3) of development (dvUPR<sup>mt</sup>) (<xref ref-type="fig" rid="fig2">Figure 2A, B</xref>). These results are consistent with previous reports demonstrating that the UPR<sup>mt</sup> is robustly induced during development but poorly induced during adulthood in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib24">Durieux et al., 2011</xref>; <xref ref-type="bibr" rid="bib44">Labbadia and Morimoto, 2015</xref>). Treating worms with FCCP during adulthood did not induce the UPR<sup>mt</sup> (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>), indicating that loss of MMP per se is not sufficient to induce the UPR<sup>mt</sup> during adulthood. Post-developmental loss of OSCP/<italic>atp-3</italic> increased endogenous transcript levels of <italic>hsp-6</italic> as well as endogenous HSP-6/mtHSP70 protein levels (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B, C</xref>, <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref>). Post-developmental loss of OSCP/<italic>atp-3</italic> mildly induced the mitochondrial chaperone reporter p<italic>hsp-60::</italic>GFP (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D, E</xref>). Neither the UPR<sup>ER</sup> nor the HSR were induced by post-developmental loss of OSCP/<italic>atp-3</italic> (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>). RNAi of other mitochondrial genes that are known to induce a dvUPR<sup>mt</sup>, <italic>clk-1</italic> (coenzyme Q hydroxylase), <italic>mrps-5</italic> (mitochondrial ribosome), and <italic>tomm-22</italic> (translocase of outer mitochondrial membrane) (<xref ref-type="bibr" rid="bib8">Baker et al., 2012</xref>; <xref ref-type="bibr" rid="bib12">Bennett et al., 2014</xref>; <xref ref-type="bibr" rid="bib37">Houtkooper et al., 2013</xref>), did not induce the pdvUPR<sup>mt</sup> (<xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). Importantly, we found that the pdvUPR<sup>mt</sup> was dependent on the master UPR<sup>mt</sup> transcription factor, <italic>atfs-1</italic> (<xref ref-type="fig" rid="fig2">Figure 2C</xref>; <xref ref-type="bibr" rid="bib33">Haynes et al., 2010</xref>), demonstrating that the pdvUPR<sup>mt</sup> is regulated similarly to the previously described dvUPR<sup>mt</sup>. Thus, loss of OSCP/<italic>atp-3</italic> induces a robust and specific pdvUPR<sup>mt</sup>, which is dependent on the conserved transcription factor ATFS-1.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Loss of OSCP/<italic>atp-3</italic> during adulthood initiates a unique UPR<sup>mt</sup> and shortens lifespan.</title><p>(<bold>A</bold>) Photomicrographs of p<italic>hsp-6</italic>::GFP reporter after developmental or post-developmental RNA interference (RNAi) of OXPHOS subunits. For developmental treatment, worms were exposed to RNAi beginning from eggs for 72 hr. For post-developmental treatment, worms were exposed to RNAi beginning from young adulthood for 48 hr. CV: control vector; dev: development; post-dev: post-development. (<bold>B</bold>) Quantification of GFP intensity from (<bold>A</bold>). Data are the mean ± SEM of ≤ 15 animals combined from three biological experiments. *p≤0.05, **p≤0.01, and ***p≤0.0001 by Student’s <italic>t</italic>-test. dv: development; pdv: post-development; I, III, IV, and V refer to OXPHOS complexes. (<bold>C</bold>) Photomicrographs of the p<italic>hsp-6</italic>::GFP reporter after RNAi of OSCP/<italic>atp-3</italic> and <italic>atfs-1</italic>. Worms were exposed to RNAi beginning from young adulthood for 48 hr. Bar graph represents quantification of GFP intensity. Data are the mean ± SEM of ≤ 15 animals combined from three biological experiments. **p≤0.01 by Student’s <italic>t</italic>-test. CV: control vector RNAi; pdv: post-development. (<bold>D</bold>) Survival curves of wild-type N2 animals on CV or OSCP/<italic>atp-3</italic> RNAi. For developmental RNAi, worms were treated continuously since eggs. For post-developmental RNAi, worms were treated for 48 hr beginning at young adulthood. Representative curves selected from three biological experiments. ***p≤0.0001 by log rank (Mantel–Cox). (<bold>E–H</bold>) Survival curves of wild-type N2 animals on indicated RNAi initiated at young adulthood for 48 hr. Representative curves selected from three biological experiments. **p≤0.01 by log rank (Mantel–Cox). (<bold>I</bold>) Survival curves of <italic>atfs-1(tm4525)</italic> when OSCP/<italic>atp-3</italic> RNAi is initiated at young adulthood for 48 hr. Representative curves selected from three biological experiments. **p≤0.01 by log rank (Mantel–Cox). Bar graph is a quantification of percent change in lifespan of N2 or <italic>atfs-1(tm4525)</italic> mutant. **p≤0.01 by Student's <italic>t</italic>-test is the mean of the percent change in lifespan ± SEM from three biological experiments.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>List of genes tested for whether they induce a developmental UPR<sup>mt</sup> (dvUPR<sup>mt</sup>) or post-developmental UPR<sup>mt</sup> (pdvUPR<sup>mt</sup>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63453-fig2-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Summary of lifespans.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63453-fig2-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63453-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Loss of the OSCP/<italic>atp-3</italic> during adulthood induces a specific post-developmental UPR<sup>mt</sup>.</title><p>(<bold>A</bold>) Dose–response of FCCP, the mitochondrial uncoupler, on the p<italic>hsp-6</italic>::GFP reporter. Quantification of the two highest doses of FCCP from the p<italic>hsp-6</italic>::GFP. (<bold>B</bold>) qPCR of <italic>hsp-6</italic> and <italic>hsp-60</italic> from N2 worms on post-developmental CV or OSCP/<italic>atp-3</italic> RNAi. Data are the mean ± SEM of ≤ 150 animals combined from four biological experiments. **p≤0.01, n.s. not significant by Student’s <italic>t</italic>-test. CV: control vector RNAi. (<bold>C</bold>) Western blot of mtHSP70/HSP-6 and tubulin (loading control) from worms on post-developmental CV or <italic>atp-3</italic> RNAi. Representative blot from three biological experiments. (<bold>D</bold>) Quantification of p<italic>hsp-6</italic>::GFP and p<italic>hsp-60</italic>::GFP reporters from (<bold>E</bold>). Data are the mean ± SEM of ≤ 15 animals combined from three biological experiments. **p≤0.01, *p≤0.05 by Student’s <italic>t</italic>-test. (<bold>E</bold>) Post-developmental RNAi of OSCP/<italic>atp-3</italic> mildly induced the mitochondrial p<italic>hsp-60</italic>::GFP reporter but not the UPR<sup>ER</sup> p<italic>hsp-4</italic>::GFP or heat shock response (HSR) p<italic>hsp-16.2</italic>::GFP reporters. Left panel: fluorescent channel; right panel: bright-field channel. (<bold>F</bold>) Survival curves of wild-type N2 treated with or without developmental COX5B/<italic>cco-1</italic> RNAi (from eggs until young adulthood) followed by post-developmental treatment with OSCP/<italic>atp-3</italic> RNAi (for 48 hr and then transferred to regular nematode growth medium (NGM) plates for the remainder of the lifespan). Lifespan curves from two pooled biological replicates. dev: developmental; pdev: post-developmental.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Source data for immunoblot (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>).</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-63453-fig2-figsupp1-data1-v1.jpg.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63453-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>The post-developmental UPR<sup>mt</sup> is temporally confined and reversible.</title><p>(<bold>A</bold>) Post-developmental RNA interference (RNAi) of OSCP/<italic>atp-3</italic> or COX5B/<italic>cco-1</italic> RNAi that was initiated at L4, young adult, and adult stages using the p<italic>hsp-6</italic>::GFP reporter at 25°C. GFP expression was assessed 48 hr after RNAi initiation. Representative pictures from two biological experiments. (<bold>B</bold>) The p<italic>hsp-6</italic>::GFP reporter worms were treated with developmental or post-developmental OSCP/<italic>atp-3</italic> RNAi. Worms were removed from HT115 RNAi bacteria and placed onto OP50 bacteria and GFP expression was assessed at indicated timepoints. Representative pictures from two biological experiments.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63453-fig2-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Loss of OSCP/<italic>atp-3</italic> during adulthood shortens lifespan</title><p>Previous reports have shown that loss of OSCP/<italic>atp-3</italic> initiated during development robustly increases lifespan in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib23">Dillin et al., 2002</xref>), but how loss of OXPHOS subunits during adulthood affects lifespan has not been well studied. We initiated OSCP/<italic>atp-3</italic> RNAi during both development and post-development. As previously reported, we found that continuous RNAi treatment initiated during development (beginning from eggs) led to lifespan extension (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>). Worms continuously exposed to OSCP/<italic>atp-3</italic> RNAi during post-development experienced a high incidence of matricide (data not shown). To circumvent this outcome, we administered OSCP/<italic>atp-3</italic> RNAi to young adults for 48 hr of adulthood and observed approximately a 38% decrease in lifespan independent of matricide (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>). Loss of other OXPHOS subunits had little or no effect on lifespan when administered during adulthood for 48 hr (<xref ref-type="fig" rid="fig2">Figure 2E–H</xref>, <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>). Surprisingly, when putative null <italic>atfs-1(tm4525)</italic> mutants were exposed to OSCP/<italic>atp-3</italic> RNAi during adulthood for 48 hr, we observed only about a 19% decrease in lifespan, suggesting that the initiation of the pdvUPR<sup>mt</sup> via <italic>atfs-1</italic> contributes to reduced lifespan (<xref ref-type="fig" rid="fig2">Figure 2I</xref>, <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>). Thus, we have identified that loss of OSCP/<italic>atp-3</italic> has distinct effects in lifespan depending on if RNAi is initiated during adulthood versus development, which has not been previously described in <italic>C. elegans.</italic></p><p>To further probe the developmental versus post-developmental effects on longevity from the loss of OSCP/<italic>atp-3</italic>, we tested how post-developmental RNAi of OSCP/<italic>atp-3</italic> would affect the longevity of worms treated with COX5B/<italic>cco-1</italic> RNAi during development, which has been shown to be sufficient to extend lifespan (<xref ref-type="bibr" rid="bib24">Durieux et al., 2011</xref>). Developmental treatment with COX5B/<italic>cco-1</italic> RNAi followed by post-developmental treatment with OSCP/<italic>atp-3</italic> RNAi did not significantly alter the long-lived lifespan (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>, <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>), suggesting that the effects of developmental COX5B/<italic>cco-1</italic> RNAi override the post-developmental effects of OSCP/<italic>atp-3</italic> RNAi, potentially due to the epigenetic remodeling that occurs during development (<xref ref-type="bibr" rid="bib50">Merkwirth et al., 2016</xref>; <xref ref-type="bibr" rid="bib73">Tian et al., 2016</xref>; <xref ref-type="bibr" rid="bib81">Zhu et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Shao et al., 2020</xref>).</p></sec><sec id="s2-4"><title>The post-developmental UPR<sup>mt</sup> is temporally confined and reversible</title><p>Given that the UPR<sup>mt</sup> has not been studied during adulthood in <italic>C. elegans,</italic> we sought to determine the window of the UPR<sup>mt</sup> during adulthood. We initiated RNAi of OSCP/<italic>atp-3</italic> beginning at the last larval stage (L4 stage) and every few hours thereafter into adulthood. GFP expression was examined 48 hr after RNAi initiation (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). We observed that the pdvUPR<sup>mt</sup> was initiated up to 6 hr after the L4 stage, after which RNAi of OSCP/<italic>atp-3</italic> no longer induced the UPR<sup>mt</sup>. In contrast, RNAi of COX5B/<italic>cco-1</italic> of complex IV had no effects on the UPR<sup>mt</sup> at any of these stages (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). For all subsequent post-development experiments, RNAi was therefore administered at the young adult stage corresponding to 4 hr after the L4 stage. Thus, the pdvUPR<sup>mt</sup> is confined to pre-gravid stages of adulthood, corresponding with previous reports showing a global decline in stress responses at the onset of egg-laying (<xref ref-type="bibr" rid="bib44">Labbadia and Morimoto, 2015</xref>).</p><p>Previous studies have shown that developmental RNAi of COX5B/<italic>cco-1</italic> RNAi leads to persistent activation of the UPR<sup>mt</sup> into adulthood, even after removal from RNAi (<xref ref-type="bibr" rid="bib24">Durieux et al., 2011</xref>). Similarly, we observed that developmental RNAi of OSCP/<italic>atp-3</italic> initiated a UPR<sup>mt</sup> that persisted into adulthood, even after removal from OSCP/<italic>atp-3</italic> RNAi (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>). In contrast, removal from post-developmental OSCP/<italic>atp-3</italic> RNAi treatment led to a steady decline in the GFP signal (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>), suggesting the activation of the pdvUPR<sup>mt</sup> is reversible.</p></sec><sec id="s2-5"><title>The post-developmental UPR<sup>mt</sup> is dependent on mPTP factors</title><p>To determine if the pdvUPR<sup>mt</sup> is initiated in response to the mPTP, we tested pharmacological and genetic modulators of the mPTP on induction of the pdvUPR<sup>mt</sup>. CsA binds cyclophilins, which in the cytoplasm regulates calcineurin signaling (<xref ref-type="bibr" rid="bib47">Liu et al., 1991</xref>; <xref ref-type="bibr" rid="bib72">Takahashi et al., 1989</xref>), while in the mitochondria inhibits the mPTP (<xref ref-type="bibr" rid="bib61">Nicolli et al., 1996</xref>). To parse out the mitochondrial versus cytoplasmic functions of CsA, we also tested the cytoplasmic-only immunosuppressive drug, FK506, which acts similarly to CsA in that it modulates calcineurin signaling in the cytoplasm (<xref ref-type="bibr" rid="bib47">Liu et al., 1991</xref>). We observed that CsA strongly inhibited the pdvUPR<sup>mt</sup> but not dvUPR<sup>mt</sup> in a dose-dependent manner (<xref ref-type="fig" rid="fig3">Figure 3A, C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). In contrast, we found that FK506 had no effect on the pdvUPR<sup>mt</sup> (<xref ref-type="fig" rid="fig3">Figure 3A, C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>), demonstrating that CsA acts in the mitochondria to suppress the pdvUPR<sup>mt</sup>. The mPTP has been shown to be regulated by adenine nucleotide translocases (ANTs) of the inner mitochondrial membrane and loss of ANTs helps prevent the mPTP (<xref ref-type="bibr" rid="bib40">Karch et al., 2019</xref>). We tested <italic>ant-1.1</italic>, which is ubiquitously expressed in <italic>C. elegans</italic>, and <italic>ant-1.2</italic>, which is expressed predominantly in the pharynx and intestines (<xref ref-type="bibr" rid="bib25">Farina et al., 2008</xref>). RNAi of <italic>ant-1.1</italic> moderately suppressed the pdvUPR<sup>mt</sup> (<xref ref-type="fig" rid="fig3">Figure 3E</xref>) while RNAi of <italic>ant-1.2</italic> strongly suppressed the pdvUPR<sup>mt</sup>, but not the dvUPR<sup>mt</sup> (<xref ref-type="fig" rid="fig3">Figure 3B, D</xref>). In mammals, CsA acts in the mitochondria to inhibit the mPTP by binding and sequestering cyclophilin D, a peptidyl prolyl isomerase (<xref ref-type="bibr" rid="bib61">Nicolli et al., 1996</xref>). <italic>C. elegans</italic> contains 17 poorly defined cyclophilins, of which two are predicted to be mitochondrially localized, <italic>cyn-1</italic> and <italic>cyn-17</italic> (<xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). RNAi of <italic>cyn-1</italic> did not inhibit the pdvUPR<sup>mt</sup> (<xref ref-type="fig" rid="fig3">Figure 3F</xref>) while <italic>cyn-17</italic> did (<xref ref-type="fig" rid="fig3">Figure 3B, D</xref>) suggesting that <italic>cyn-17</italic> may act similarly to cyclophilin D in mediating a conformation change that leads to the mPTP. RNAi of <italic>cyn-17</italic> did not affect the dvUPR<sup>mt</sup> (<xref ref-type="fig" rid="fig3">Figure 3B, D</xref>). Finally, we observed that CysA was able to reverse the lifespan shortening caused by OSCP/<italic>atp-3</italic> RNAi (<xref ref-type="fig" rid="fig3">Figure 3G</xref>), demonstrating that inhibition of the UPR<sup>mt</sup> can be beneficial under certain conditions. Together, these results show that the pdvUPR<sup>mt</sup> is regulated by canonical pharmacological and genetic mPTP factors.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>The post-developmental UPR<sup>mt</sup> is regulated by pharmacological and genetic modulators of the mitochondrial permeability transition pore (mPTP).</title><p>(<bold>A, B</bold>) Photomicrographs of p<italic>hsp-6</italic>::GFP reporter after developmental or post-developmental RNA interference (RNAi) and drug treatments (cyclosporin A (CsA) and FK506, 15 μM). For developmental treatment, worms were treated beginning from eggs for 72 hr. For post-developmental treatment, worms were treated beginning from young adulthood for 48 hr. dev: development; post-dev: post-development. (<bold>C, D</bold>) Quantification of GFP intensity from (<bold>A, B</bold>). Data are the mean ± SEM of ≤ 15 animals combined from three biological experiments. *p≤0.05,***p≤0.0001 by Student’s <italic>t</italic>-test; n.s., not significant; CV: control vector. (<bold>E, F</bold>) Quantification of GFP intensity from p<italic>hsp-6</italic>::GFP reporter after RNAi treatment for 48 hr beginning from young adulthood. (<bold>G</bold>) Survival curves of wild-type N2 animals on CV or OSCP/<italic>atp-3</italic> RNAi with either solvent control or CsA (15 μM). RNAi and CsA were administered beginning at young adulthood for 48 hr and then transferred to regular nematode growth medium (NGM) plates for the remainder of the lifespan. Representative curves selected from three biological experiments. ***p≤0.0001 by log rank (Mantel–Cox).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>List of <italic>C. elegans</italic> cyclophilins and their predicted mitochondrial localization using the MitoFates mitochondrial targeting sequence (MTS) prediction tool.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63453-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63453-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Loss of OSCP/<italic>atp-3</italic> during adulthood recapitulates mitochondrial permeability transition pore (mPTP) characteristics.</title><p>(<bold>A</bold>) Dose–response of cyclosporin A (CsA) administered during development or post-development on OSCP/<italic>atp-3</italic> RNA interference (RNAi)-treated p<italic>hsp-6</italic>::GFP reporter worms. Developmental RNAi was administered beginning from eggs for 72 hr. Post-developmental RNAi was administered for 48 hr beginning from young adulthood. (<bold>B</bold>) Dose–response of FK506 administered during post-development on OSCP/<italic>atp-3</italic> RNAi-treated p<italic>hsp-6</italic>::GFP reporter worms. Post-developmental RNAi was administered for 48 hr beginning from young adulthood.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63453-fig3-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-6"><title>Loss of F-ATP synthase ATPases induces a post-developmental UPR<sup>mt</sup></title><p>F-ATP synthase is composed of a membrane-bound proton-driving rotor (Fo), a catalytic ATPase that converts ADP to ATP (F1), and peripheral stalk and supernumerary subunits that help bridge these two portions together (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). OSCP/<italic>atp-</italic>3 sits on the ATPase and helps tether it to the peripheral stalk subunits. We systematically tested via RNAi whether loss of F-ATP synthase subunits other than OSCP/<italic>atp-3</italic> could induce a pdvUPR<sup>mt</sup>. During development, loss of rotor subunits, ATPase subunits, or peripheral stalk and supernumerary subunits all induced a robust UPR<sup>mt</sup> (<xref ref-type="fig" rid="fig4">Figure 4A, C</xref>). In contrast, during adulthood, loss of rotor subunits (c-ring/<italic>Y82E9BR.3</italic>), peripheral stalk or supernumerary subunits (F6/<italic>atp-4</italic>, d/<italic>atp-5</italic>, b/<italic>asb-2</italic>, e/<italic>R04F11.2</italic>, f/<italic>R53.4</italic>), induced little to no UPR<sup>mt</sup> (<xref ref-type="fig" rid="fig4">Figure 4B, D</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). Loss of the ATPase subunits (α/<italic>atp-1</italic>, β/<italic>atp-2</italic>, δ/<italic>F58F12.1,</italic> ε/<italic>hpo-18</italic>) induced a mild to moderate UPR<sup>mt</sup>, though none as robustly as loss of OSCP/<italic>atp-3</italic>. We observed that post-developmental loss of the α/<italic>atp-1</italic> ATPase subunit exhibited the second most robust pdvUPR<sup>mt</sup> (<xref ref-type="fig" rid="fig4">Figure 4B, D</xref>) but did not induce a loss of MMP or a rise in cytosolic Ca<sup>2+</sup> (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>). Consistently, we observed a minor shortening of survival due to post-developmental RNAi of α/<italic>atp-1</italic> (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). These findings support our hypothesis that loss of OSCP/<italic>atp-3</italic>, but not other F-ATP synthase subunits, activates an mPTP that is coupled to a maladaptive pdvUPR<sup>mt</sup>.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Loss of F-ATP synthase ATPases induces a post-developmental UPR<sup>mt</sup>.</title><p>(<bold>A</bold>) Developmental RNA interference (RNAi) of all ATP synthase subunits tested induced the p<italic>hsp-6</italic>::GFP reporter. For developmental treatment, worms were exposed to RNAi beginning from eggs for 72 hr. (<bold>B</bold>) Post-developmental RNAi of ATPase and c-ring subunits but not peripheral stalk or supernumerary subunits of the F-ATP synthase induced the p<italic>hsp-6</italic>::GFP reporter. Worms were exposed to RNAi beginning from young adulthood for 48 hr. post-dev: post-development. (<bold>C</bold>) Quantification of GFP intensity from (<bold>A</bold>). Data are the mean ± SEM of ≤ 15 animals combined from three biological experiments. ***p≤0.0001 by Student’s <italic>t</italic>-test. dv: developmental. (<bold>D</bold>) Quantification of GFP intensity from (<bold>B</bold>). Data are the mean ± SEM of ≤ 15 animals combined from three biological experiments. *p≤0.05, **p≤0.01, and ***p≤0.0001 by Student’s <italic>t</italic>-test. pdv: post-developmental. (<bold>E</bold>) Schematic of monomeric F-ATP synthase. White subunits: ATPase; black subunits: H+-rotor/c-ring; gray subunits: peripheral stalk and supernumerary subunits; red subunit: oligomycin sensitivity-conferring protein (OSCP/<italic>atp-3</italic>). (<bold>F</bold>) Survival curves of wild-type N2 animals on CV or α/<italic>atp-1</italic> RNAi initiated at young adulthood for 48 hr. Pooled survival curves from four biological experiments. **p≤0.01 by log rank (Mantel–Cox). CV: control vector.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Summary of the effects of RNA interference (RNAi) of F-ATP synthase subunits on the developmental UPR<sup>mt</sup> (dvUPR<sup>mt</sup>) or post-developmental UPR<sup>mt</sup> (pdvUPR<sup>mt</sup>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63453-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63453-fig4-v1.tif"/></fig></sec><sec id="s2-7"><title>Loss of F-ATP synthase subunits important for the formation of the mPTP suppresses the post-developmental UPR<sup>mt</sup></title><p>Current models posit that the F-ATP synthase forms a pore that is capable of releasing Ca<sup>2+</sup> under conditions of high oxidative stress, leading to rupturing of the mitochondria and initiation of cell death cascades. Some models suggest that F-ATP synthase dimers form the mPTP (<xref ref-type="fig" rid="fig5">Figure 5E</xref>) and that peripheral and supernumerary subunits are essential for pore formation (<xref ref-type="bibr" rid="bib17">Carraro et al., 2014</xref>; <xref ref-type="bibr" rid="bib29">Giorgio et al., 2013</xref>; <xref ref-type="bibr" rid="bib31">Guo et al., 2019</xref>; <xref ref-type="bibr" rid="bib74">Urbani et al., 2019</xref>). Other models demonstrate that F-ATP synthase monomers are sufficient for the mPTP and specify the c-ring proton-driving rotor as the actual pore-forming component (<xref ref-type="fig" rid="fig5">Figure 5F</xref>; <xref ref-type="bibr" rid="bib1">Alavian et al., 2014</xref>; <xref ref-type="bibr" rid="bib6">Azarashvili et al., 2014</xref>; <xref ref-type="bibr" rid="bib15">Bonora et al., 2013</xref>; <xref ref-type="bibr" rid="bib16">Bonora et al., 2017</xref>; <xref ref-type="bibr" rid="bib51">Mnatsakanyan et al., 2019</xref>; <xref ref-type="bibr" rid="bib60">Neginskaya et al., 2019</xref>). To determine whether the structural integrity of F-ATP synthase subunits was required for the pdvUPR<sup>mt</sup>, we systematically knocked down OSCP/<italic>atp-3</italic> as well as one additional F-ATP synthase subunit via RNAi. When we knocked down the c-ring subunits (color coded black) as well as peripheral and supernumerary subunits (color coded gray) via RNAi in adults, we observed nearly complete inhibition of the OSCP/<italic>atp-3</italic> RNAi-mediated pdvUPR<sup>mt</sup> (<xref ref-type="fig" rid="fig5">Figure 5B, D</xref>). When we knocked down the ATPase subunits (color coded white) in adults, we observed that loss of the β/<italic>atp-2</italic> subunit robustly suppressed the OSCP/<italic>atp-3</italic> RNAi-mediated pdvUPR<sup>mt</sup>, possibly due to its role in modulating Ca<sup>2+</sup> in the mPTP, while loss of α/<italic>atp-1</italic> moderately inhibited the pdvUPR<sup>mt</sup> (<xref ref-type="fig" rid="fig5">Figure 5B, D</xref>). Loss of the ATPase subunits δ/<italic>F58F12.1</italic> or ε/<italic>hpo-18</italic> in adults did not affect the pdvUPR<sup>mt</sup> (<xref ref-type="fig" rid="fig5">Figure 5B, D</xref>). In contrast, dual loss of subunits during development all robustly activated the dvUPR<sup>mt</sup> (<xref ref-type="fig" rid="fig5">Figure 5A, C</xref>). Dual loss of subunits from other OXPHOS complexes (NDUFS3/<italic>nuo-2</italic>, complex I; COX5B/<italic>cco-1</italic>, complex IV) had no effect or slightly increased the dvUPR<sup>mt</sup> and the pdvUPR<sup>mt</sup> (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A, B</xref>). Thus, we find subunits critical for dimerization (peripheral and supernumerary subunits) and proton translocation (c-ring rotor) are required to transduce the OSCP/<italic>atp-3</italic> RNAi-mediated pdvUPR<sup>mt</sup>. We also find that the β/<italic>atp-2</italic> subunit, previously found to play an important role in Ca<sup>2+</sup> mediated mPTP (<xref ref-type="bibr" rid="bib30">Giorgio et al., 2017</xref>), is required to transduce the OSCP/<italic>atp-3</italic> RNAi-mediated pdvUPRmt. Taken together, these findings support a model in which inhibition of the mPTP via deletion of critical F-ATP synthase subunits inhibits the pdvUPR<sup>mt</sup>.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Loss of F-ATP synthase subunits important for the formation of the mitochondrial permeability transition pore (mPTP) suppresses the post-developmental UPR<sup>mt</sup>.</title><p>(<bold>A, B</bold>) Concomitant RNA interference (RNAi) of OSCP/<italic>atp-3</italic> and individual F-ATP synthase subunits during developmental (<bold>A</bold>) or post-developmental (<bold>B</bold>) modulated the UPR<sup>mt</sup> to varying degrees in the p<italic>hsp-6</italic>::GFP reporter strain. (<bold>C, D</bold>) Quantification of GFP intensity from (<bold>A, B</bold>). Data are the mean ± SEM of ≤ 15 animals combined from three biological experiments. **p≤0.001, ***p≤0.0001 compared to control vector (CV) + <italic>atp-3</italic> condition by Student’s <italic>t</italic>-test. dv: developmental; pdv: post-developmental. (<bold>E, F</bold>) Models of F-ATP synthase forming a dimeric mPTP (<bold>E</bold>) or monomeric mPTP (<bold>F</bold>). White subunits: ATPase; black subunits: H+ rotor/c-ring; gray subunits: peripheral stalk and supernumerary subunits; red subunit: oligomycin sensitivity-conferring protein (OSCP/<italic>atp-3</italic>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63453-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Effects of loss of OXPHOS subunits on the dvUPR<sup>mt</sup> and pdvUPR<sup>mt</sup>.</title><p>(<bold>A, B</bold>) Concomitant developmental (<bold>A</bold>) or post-developmental (<bold>B</bold>) RNA interference (RNAi) of <italic>atp-3</italic> and either <italic>cco-1</italic> or <italic>nuo-2</italic> induced the p<italic>hsp-6</italic>::GFP reporter. For developmental treatment, worms were exposed to RNAi beginning from eggs for 72 hr. For post-developmental treatment, worms were exposed to RNAi from young adulthood for 48 hr. Bar graphs are the mean ± SEM of ≤ 15 animals combined from three biological experiments. ** p≤0.0001, ***p≤0.0001 by Student’s <italic>t</italic>-test. n.s., no significant differences from control vector (CV) + <italic>atp-3</italic> condition; dvUPR<sup>mt</sup>: development; pdv: post-development. (<bold>C</bold>) Dual-RNAi effectively knocks down ATP-3 protein synthesis as measured by the translational p<italic>atp-3</italic>::ATP-3::GFP reporter. (i) 10× photomicrographs of homozygous and heterozygous (bright pharyngeal GFP expression) worms. (ii) 40× photomicrographs of head region of control homozygous worms. (iii) 40× photomicrographs of mid-region of control homozygous worms. (iv) 40× photomicrographs of tail region of control homozygous worms. (<bold>D</bold>) RNAi of α/<italic>atp-1</italic> induces a post-developmental UPR<sup>mt</sup> similar to OSCP/<italic>atp-3</italic> in the p<italic>hsp-6</italic>::GFP reporter. Representative results from two biological experiments. Immunoblot of ATP-1 from p<italic>hsp-6</italic>::GFP reporter worms after dual-RNAi treatment for 48 hr. Representative blots from two biological experiments.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Source data for immunoblot (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>).</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-63453-fig5-figsupp1-data1-v1.jpg.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63453-fig5-figsupp1-v1.tif"/></fig></fig-group><p>To verify that the use of dual-RNAi did not interfere with knockdown of OSCP/<italic>atp-3</italic>, we assessed an endogenously expressing p<italic>atp-3</italic>::ATP-3::GFP translational reporter generated via CRISPR-Cas-9 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). We observed efficient knockdown of ATP-3 via RNAi in the presence of either β/<italic>atp-2</italic> or d/<italic>atp-5</italic> RNAi, two subunits that suppress the pdvUPR<sup>mt</sup>. These findings demonstrate that inhibition of the pdvUPR<sup>mt</sup> is not due to ineffective RNAi of OSCP/<italic>atp-3</italic> but rather the functional consequence of removing additional F-ATP synthase subunits. To examine the effects of dual-RNAi another way, we examined how loss of F-ATP synthase subunits impacted the pdvUPR<sup>mt</sup> after α/<italic>atp-1</italic> RNAi, which induced the second most robust pdvUPR<sup>mt</sup> (<xref ref-type="fig" rid="fig4">Figure 4B, D</xref>). Remarkably, we see the same pattern of pdvUPR<sup>mt</sup> activation and inhibition as with loss of OSCP/<italic>atp-3</italic>: loss of the ATPase subunit β/<italic>atp-2</italic> and peripheral stalk subunit d/<italic>atp-5</italic> suppressed the α/<italic>atp-1</italic> RNAi-mediated pdvUPR<sup>mt</sup> while loss of NDUFS3/<italic>nuo-2</italic> and COX5B/<italic>cco-1</italic> had no effect (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). Importantly, immunoblots against α<italic>/atp-1</italic> showed similar protein knockdown under all conditions (<xref ref-type="supplementary-material" rid="fig5s1sdata1">Figure 5—figure supplement 1—source data 1</xref>), confirming that dual-RNAi is an effective method to assess the structural components of the F-ATP synthase.</p></sec><sec id="s2-8"><title>Loss of F-ATP synthase subunits important for the formation of the mPTP reverses mPTP characteristics and regulates longevity</title><p>Based on our observations that loss of peripheral stalk subunits is capable of suppressing the pdvUPR<sup>mt</sup>, we tested if their loss would also suppress mPTP characteristics. RNAi of peripheral stalk subunits (F6/<italic>atp-4</italic>, d/<italic>atp-5</italic>) or the proton-driving rotor c-ring/<italic>Y82E9BR.3</italic> rescued the loss in MMP, suppressed the rise in cytosolic Ca<sup>2+</sup>, and rescued the shortened lifespan caused by RNAi of OSCP/<italic>atp-3</italic> (<xref ref-type="fig" rid="fig6">Figure 6A–G</xref>, <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>). Interestingly, RNAi of b/<italic>asb-2</italic> did not rescue the loss in membrane potential but did inhibit the rise in cytosolic Ca<sup>2+</sup> and rescued lifespan (<xref ref-type="fig" rid="fig6">Figure 6A–D</xref>, <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>). We further examined the intestinal mitochondrial morphology in worms dually treated with OSCP/<italic>atp-3</italic> and either F6/<italic>atp-4</italic>, d/<italic>atp-5</italic>, or c-ring/<italic>Y82E9BR.3</italic> RNAi. Though RNAi of the peripheral and rotor subunits on its own caused aberrant mitochondrial morphology distinct from controls, RNAi treatment rescued the rounded and swollen mitochondrial morphology observed due to OSCP/<italic>atp-3</italic> RNAi (<xref ref-type="fig" rid="fig6">Figure 6I–L</xref>). Thus, inhibition of key subunits of F-ATP synthase generally reverses the detrimental effects associated with the mPTP/pdvUPR<sup>mt</sup> nexus.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Reversal of mitochondrial permeability transition pore (mPTP) characteristics and regulation of longevity by F-ATP synthase subunits.</title><p>(<bold>A</bold>) Testing for epistatic interactions between OSCP/<italic>atp-3</italic> and F-ATP synthase subunits on the mitochondrial membrane potential (MMP). RNA interferences (RNAis) were concomitantly administered beginning at young adulthood for 48 hr. Tetramethylrhodamine methyl ester (TMRM) was spotted on seeded plates. Data are the mean ± SEM of ≤ 15 animals combined from four biological experiments. *p≤0.05, **p≤0.01 by Student’s <italic>t</italic>-test. CV: control vector. (<bold>B</bold>) Testing for epistatic interactions between OSCP/<italic>atp-3</italic> and F-ATP synthase subunits on cytosolic Ca<sup>2+</sup> using the FRET-based calcium indicator protein D3cpv/cameleon. RNAis were concomitantly administered beginning at young adulthood for 48 hr. Data are the mean ± SEM of ≤ 15 animals combined from three biological experiments. **p≤0.01 by Student’s <italic>t</italic>-test. (<bold>C–G</bold>) Testing for epistatic interactions between OSCP/<italic>atp-3</italic> and F-ATP synthase subunits on the survival. Survival curves of wild-type N2 animals treated with RNAi beginning at young adulthood for 48 hr and then transferred to regular nematode growth medium (NGM) plates for the remainder of the lifespan. Lifespan curves from two pooled biological replicates. ***p≤0.0001 by log rank (Mantel–Cox). (<bold>H</bold>) Survival curves of wild-type N2 animals on CV or CV/c-ring subunit. Lifespan curves from two pooled biological replicates. ***p≤0.0001 by log rank (Mantel–Cox). CV: control vector RNAi. (<bold>I–L</bold>) Testing for epistatic interactions between OSCP/<italic>atp-3</italic> and F-ATP synthase subunits on mitochondrial morphology. Confocal micrographs of intestinal mitochondria labeled with GFP (p<italic>ges-1</italic>::GFP<sup>mt</sup>) treated with RNAi for 48 hr beginning at young adulthood. Worms were then removed from the RNAi and aged until day 7 of adulthood followed by collection for microscopy. Top panels: fluorescent channel; bottom panels: rendering of individual mitochondria. See Materials and methods for details on rendering.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63453-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Post-developmental loss of F-ATP synthase peripheral stalk subunits.</title><p>(<bold>A–C</bold>) Survival curves of wild-type N2 worms on indicated RNA interference (RNAi). RNAi was administered starting from young adulthood for 48 hr and then transferred to regular nematode growth medium (NGM) plates for the remainder of the lifespan. Pooled survival curves from two biological experiments.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63453-fig6-figsupp1-v1.tif"/></fig></fig-group><p>While testing the epistatic relationship of the F-ATP synthase subunits, we observed that post-developmental RNAi of c-ring/<italic>Y82E9BR.3</italic> on its own was sufficient to significantly extend lifespan (<xref ref-type="fig" rid="fig6">Figure 6H</xref>), while the loss of the b/<italic>asb-2</italic>, F6/<italic>atp-4</italic>, and d/<italic>atp-5</italic> peripheral stalk subunits did not (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>). Similarly, we had previously observed that loss of the α/<italic>atp-1</italic> and β/<italic>atp-2</italic> ATPase subunits had minor lifespan shortening effects (<xref ref-type="fig" rid="fig2">Figures 2H</xref> and <xref ref-type="fig" rid="fig3">3F</xref>). Thus, loss of the proton-driving c-ring during adulthood uniquely extends lifespan, which is particularly intriguing due to the fact that a plethora of evidence supports a role for the c-ring as the pore-forming component of mPTP (<xref ref-type="bibr" rid="bib1">Alavian et al., 2014</xref>; <xref ref-type="bibr" rid="bib6">Azarashvili et al., 2014</xref>; <xref ref-type="bibr" rid="bib15">Bonora et al., 2013</xref>; <xref ref-type="bibr" rid="bib16">Bonora et al., 2017</xref>; <xref ref-type="bibr" rid="bib51">Mnatsakanyan et al., 2019</xref>; <xref ref-type="bibr" rid="bib60">Neginskaya et al., 2019</xref>) and its involvement in disease (<xref ref-type="bibr" rid="bib2">Amodeo et al., 2021</xref>; <xref ref-type="bibr" rid="bib45">Licznerski et al., 2020</xref>; <xref ref-type="bibr" rid="bib53">Morciano et al., 2021</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>While loss of the F-ATP synthase subunit OSCP/<italic>atp-3</italic> during development leads to lasting activation of the UPR<sup>mt</sup> and is associated with longevity, we have discovered that loss of this subunit during adulthood induces the mPTP and activates a reversible and <italic>atfs-1-</italic>dependent UPR<sup>mt</sup> (pdvUPR<sup>mt</sup>). Furthermore, we observed that activation of the pdvUPR<sup>mt</sup> helps drive aging. Suppression of the mPTP/UPR<sup>mt</sup> via genetic or pharmacological interventions is protective. Loss of other OXPHOS subunits or administration of FCCP during adulthood does not cause a loss of the MMP, a rise in cytosolic Ca<sup>2+</sup>, or activation of the pdvUPR<sup>mt</sup>, suggesting that the activation of mPTP/UPR<sup>mt</sup> is specifically due to loss of OSCP/<italic>atp-3</italic>. In contrast, it does not appear that the loss of OSCP/<italic>atp-3</italic> during development activates an mPTP. Thus, loss of OSCP/<italic>atp-3</italic> can have drastically different effects depending on the life stage or cellular milieu of the organism.</p><p>While the mPTP’s detrimental effects on health are well established, considerable evidence suggests that the UPR<sup>mt</sup> contributes to health and longevity (<xref ref-type="bibr" rid="bib37">Houtkooper et al., 2013</xref>; <xref ref-type="bibr" rid="bib50">Merkwirth et al., 2016</xref>; <xref ref-type="bibr" rid="bib54">Mouchiroud et al., 2013</xref>; <xref ref-type="bibr" rid="bib71">Sorrentino et al., 2017</xref>). Activating the UPR<sup>mt</sup> in neurons can activate protective cell non-autonomous signals and also epigenetically rewire <italic>C. elegans</italic> to live longer (<xref ref-type="bibr" rid="bib24">Durieux et al., 2011</xref>; <xref ref-type="bibr" rid="bib50">Merkwirth et al., 2016</xref>; <xref ref-type="bibr" rid="bib73">Tian et al., 2016</xref>; <xref ref-type="bibr" rid="bib79">Zhang et al., 2018</xref>; <xref ref-type="bibr" rid="bib81">Zhu et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Shao et al., 2020</xref>). NAD<sup>+</sup> boosters activate a UPR<sup>mt</sup> that contributes to longevity and ameliorates AD (<xref ref-type="bibr" rid="bib54">Mouchiroud et al., 2013</xref>; <xref ref-type="bibr" rid="bib71">Sorrentino et al., 2017</xref>). However, an unbiased screen that identified activators of the UPR<sup>mt</sup> found no correlation between UPR<sup>mt</sup> activation and longevity (<xref ref-type="bibr" rid="bib12">Bennett et al., 2014</xref>) and constitutive activation of the UPR<sup>mt</sup> in dopaminergic neurons led to increased neurodegeneration (<xref ref-type="bibr" rid="bib49">Martinez et al., 2017</xref>). Activation of the UPR<sup>mt</sup> in our setting is distinct in that it is specifically linked to activation of the mPTP. Thus, it is possible that preemptively boosting the UPR<sup>mt</sup> may ward off aging and disease while activation during a diseased setting may exacerbate conditions, akin to instances of inflammation in disease.</p><p>We propose a model in which loss of OSCP/<italic>atp-3</italic> induces a conformational change in F-ATP synthase that leads to pore formation and activation of the UPR<sup>mt</sup> during adulthood but not during development. Previous reports have shown that loss of OSCP increases susceptibility to Ca<sup>2+</sup>-induced mPTP formation and that key residues within the OSCP are required to suppress the mPTP during conditions of low pH (<xref ref-type="bibr" rid="bib5">Antoniel et al., 2018</xref>; <xref ref-type="bibr" rid="bib29">Giorgio et al., 2013</xref>), suggesting that a functional and intact OSCP protects against pore formation. OSCP levels have also been shown to decrease with age while concomitantly increasing its binding to amyloid β, suggesting that loss of OSCP destabilizes the remaining F-ATP synthase to increase pore formation (<xref ref-type="bibr" rid="bib11">Beck et al., 2016b</xref>). However, it has also been shown that OSCP provides the binding site for cyclophilin D and thus it has been proposed to be critical in the formation of the mPTP (<xref ref-type="bibr" rid="bib28">Giorgio et al., 2009</xref>; <xref ref-type="bibr" rid="bib29">Giorgio et al., 2013</xref>). However, immunoprecipitation studies show that cyclophilin D my also bind the peripheral stalk subunit b, which is also supported by EM studies (<xref ref-type="bibr" rid="bib22">Daum et al., 2013</xref>; <xref ref-type="bibr" rid="bib29">Giorgio et al., 2013</xref>). Thus, our findings support a model in which loss of OSCP/<italic>atp-3</italic> induces a conformation change that is favorable for cyclophilin binding to the remaining peripheral stalk proteins or to sites independent of the F-ATP synthase, leading to destabilization of F-ATP synthase, pore formation with a loss of MMP, and subsequent activation of the pdvUPR<sup>mt</sup>.</p><p>The loss of OSCP/<italic>atp-3</italic> may also be more impactful than other subunits. Unlike other F-ATP synthase subunits, OSCP/<italic>atp-3</italic> is prominently accessible in the mitochondrial matrix and has a diverse set of binding partners, such as estradiol and p53, which can modulate ATP production (<xref ref-type="bibr" rid="bib13">Bergeaud et al., 2013</xref>; <xref ref-type="bibr" rid="bib80">Zheng and Ramirez, 1999</xref>). Its loss may induce a strong protein misfolding cascade, reminiscent of the He and Lemasters mPTP model first proposed in 2002 (<xref ref-type="bibr" rid="bib36">He and Lemasters, 2002</xref>). In this model, it was proposed that exposure to activators of the mPTP, such as oxidants, causes protein misfolding of integral membrane proteins, thereby recruiting chaperones such as cyclophilin D for repair. If the protein misfolding is unable to be repaired, then Ca<sup>2+</sup>, along with cyclophilin D, could catalyze pore formation in a CsA-dependent manner. Indeed, exposure to the oxidants paraquat and manganese have been shown to induce the UPR<sup>mt</sup> and the mPTP in separate studies (<xref ref-type="bibr" rid="bib4">Angeli et al., 2014</xref>; <xref ref-type="bibr" rid="bib21">Costantini et al., 1995</xref>; <xref ref-type="bibr" rid="bib59">Nargund et al., 2012</xref>; <xref ref-type="bibr" rid="bib65">Rao and Norenberg, 2004</xref>). However, more research is needed to clarify the relationship between protein misfolding and the mPTP.</p><p>AD and PD both display evidence of the mPTP, and in some instances, elevated UPR<sup>mt</sup> profiles have also been observed (<xref ref-type="bibr" rid="bib10">Beck et al., 2016a</xref>; <xref ref-type="bibr" rid="bib11">Beck et al., 2016b</xref>; <xref ref-type="bibr" rid="bib48">Ludtmann et al., 2018</xref>; <xref ref-type="bibr" rid="bib64">Pérez et al., 2018</xref>; <xref ref-type="bibr" rid="bib71">Sorrentino et al., 2017</xref>), but the relationship between these two mitochondrial processes has not been fully explored. Ischemic reperfusion injuries directly cause the mPTP but little is known about the UPR<sup>mt</sup> under these conditions (<xref ref-type="bibr" rid="bib41">Kaufman and Crowder, 2015</xref>). Establishing a clearer understanding of the relationship between the UPR<sup>mt</sup> and the mPTP in these disease states could result in the development of new therapeutics for these and related disorders.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or <break/>resource</th><th valign="top">Designation</th><th valign="top">Source or <break/>reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Strain, strain background (<italic>Caenorhabditis elegans</italic>)</td><td valign="top">N2 Bristol</td><td valign="top">Caenorhabditis Genetics Center</td><td valign="top">Wild-type</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Caenorhabditis elegans</italic>)</td><td valign="top">SJ4100</td><td valign="top">Caenorhabditis Genetics Center</td><td valign="top"><italic>hsp-6</italic>p::GFP</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Caenorhabditis elegans</italic>)</td><td valign="top">SJ4058</td><td valign="top">Caenorhabditis Genetics Center</td><td valign="top"><italic>hsp-60</italic>p::GFP</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Caenorhabditis elegans</italic>)</td><td valign="top">SJ4005</td><td valign="top">Caenorhabditis Genetics Center</td><td valign="top"><italic>hsp-4</italic>p::GFP</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Caenorhabditis elegans</italic>)</td><td valign="top">CL2070</td><td valign="top">Caenorhabditis Genetics Center</td><td valign="top"><italic>hsp-16.2</italic>p::GFP</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Caenorhabditis elegans</italic>)</td><td valign="top">KWN190</td><td valign="top">Caenorhabditis Genetics Center</td><td valign="top">rnyEx109[<italic>nhx-2</italic>p::D3cpv + <italic>pha-1</italic>(+)], <italic>pha-1(e2123) III;</italic> (<italic>him-5(e1490)</italic>V)</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Caenorhabditis elegans</italic>)</td><td valign="top">ZC376.7</td><td valign="top">National BioResource Project</td><td valign="top"><italic>atfs-1(tm4525)</italic></td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Caenorhabditis elegans</italic>)</td><td valign="top">PHX1826</td><td valign="top">SunyBiotech</td><td valign="top">qIs48[<italic>atp-3(syb1826)]</italic>/hT2[<italic>bli-4(e937) let-?(q782)</italic>]</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Caenorhabditis elegans</italic>)</td><td valign="top">SJ4143</td><td valign="top">Caenorhabditis Genetics Center</td><td valign="top"><italic>ges-1</italic>p::GFP(mt)</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Caenorhabditis elegans</italic>)</td><td valign="top">GL347</td><td valign="top">This study</td><td valign="top">SJ4100 backcrossed 6× to N2 Bristol</td><td valign="top"/></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-GRP 75 (D9) (mouse monoclonal)</td><td valign="top">Santa Cruz Biotechnology</td><td valign="top">sc-133137</td><td valign="top">WB(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-β tubulin (D-10) (mouse monoclonal)</td><td valign="top">Santa Cruz Biotechnology</td><td valign="top">sc-5274</td><td valign="top">WB(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-β-actin (8H10D10) (mouse monoclonal)</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat# 3700</td><td valign="top">WB(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-ATP5A1 (15H4C4) (mouse monoclonal)</td><td valign="top">Thermo Fisher</td><td valign="top">Catalog # 43-9800</td><td valign="top">WB(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-ATP synthase beta (3D5AB1) (mouse monoclonal)</td><td valign="top">Thermo Fisher</td><td valign="top">Catalog # A-21351</td><td valign="top">WB(1:1000)</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Anti-NDUFS3 (17D95) (mouse monoclonal)</td><td valign="top">Thermo Fisher</td><td valign="top">Catalog # 43-9200</td><td valign="top">WB(1:1000)</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">FCCP (trifluoromethoxycarbonylcyanidephenylhydrazone)</td><td valign="top">Cayman Chemical</td><td valign="top">Item # 15218</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">FK506 (tacrolimus)</td><td valign="top">Cayman Chemical</td><td valign="top">Item # 10007965</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Tetramethylrhodamine methyl ester (perchlorate) (TMRM)</td><td valign="top">Cayman Chemical</td><td valign="top">Item # 21437</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Cyclosporin A</td><td valign="top">Cayman Chemical</td><td valign="top">Item # 12088</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">GraphPad Prism</td><td valign="top">GraphPad Software</td><td valign="top">v.9</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">ImageJ software</td><td valign="top">ImageJ <ext-link ext-link-type="uri" xlink:href="http://imagej.nih.gov/ij/">http://imagej.nih.gov/ij/</ext-link></td><td valign="top">1.52A</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">MitoFates tool</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://mitf.cbrc.jp/MitoFates/cgi-bin/top.cgi">http://mitf.cbrc.jp/MitoFates/cgi-bin/top.cgi</ext-link> <break/>(<xref ref-type="bibr" rid="bib26">Fukasawa et al., 2015</xref>).</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>act-1</italic>, forward</td><td valign="top">This study</td><td valign="top">qPCR primers</td><td valign="top">ACGACGAGTCCGGCCCATCC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>act-1</italic>, reverse</td><td valign="top">This study</td><td valign="top">qPCR primers</td><td valign="top">GAAAGCTGGTGGTGACGATGGTT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>atp-2</italic>, forward</td><td valign="top">This study</td><td valign="top">qPCR primers</td><td valign="top">GAAGGACAAATCTCCCCACA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>atp-2</italic>, reverse</td><td valign="top">This study</td><td valign="top">qPCR primers</td><td valign="top">CGCCACATTCTTCCTTTTTC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>atp-4</italic>, forward</td><td valign="top">This study</td><td valign="top">qPCR primers</td><td valign="top">AATATGTTGCCTCCCGTGAT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>atp-4</italic>, reverse</td><td valign="top">This study</td><td valign="top">qPCR primers</td><td valign="top">GGAACAAAAACGTTCATTCG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>atp-5</italic>, forward</td><td valign="top">This study</td><td valign="top">qPCR primers</td><td valign="top">TCTTCGACGTGCCGACAA</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>atp-5</italic>, reverse</td><td valign="top">This study</td><td valign="top">qPCR primers</td><td valign="top">AAATGGTAGGAGAGCGATAAGG</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>nuo-2</italic>, forward</td><td valign="top">This study</td><td valign="top">qPCR primers</td><td valign="top">TGAAGTTGCTGAGCCAACAC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>nuo-2</italic>, reverse</td><td valign="top">This study</td><td valign="top">qPCR primers</td><td valign="top">TCCACACTAACAGAAAATGAGTCT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>cco-1</italic>, forward</td><td valign="top">This study</td><td valign="top">qPCR primers</td><td valign="top">TTTCGGCTATTGTTCGCATT</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>cco-1</italic>, reverse</td><td valign="top">This study</td><td valign="top">qPCR primers</td><td valign="top">GCCGTCTTAGCAAGTTGAGC</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>atp-3</italic>p::ATP-3::GFP</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://www.sunybiotech.com/">http://www.sunybiotech.com/</ext-link></td><td valign="top">sgRNA target site</td><td valign="top">Sg1: <underline>CCC</underline>TTGCCACCGCCATCTAAatt</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>atp-3</italic>p::ATP-3::GFP</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://www.sunybiotech.com/">http://www.sunybiotech.com/</ext-link></td><td valign="top">sgRNA target site</td><td valign="top">Sg2:<underline>CCG</underline>CCATCTAAatttttcccaaa</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Contact for reagent and resource sharing</title><p>Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contacts, Gordon Lithgow, <ext-link ext-link-type="uri" xlink:href="https://www.buckinstitute.org/lab/lithgow-lab/">glithgow@buckinstitute.org</ext-link>, Julie Andersen, <ext-link ext-link-type="uri" xlink:href="https://www.buckinstitute.org/lab/andersen-lab/">jandersen@buckinstitute.org</ext-link>, and Suzanne Angeli, <ext-link ext-link-type="uri" xlink:href="https://www.linkedin.com/in/suzanne-angeli-5b183516">suzanne.angeli@gmail.com</ext-link>. </p></sec><sec id="s4-2"><title>Nematode and bacterial culture conditions</title><p>Nematodes were maintained on nematode growth medium (NGM) plates. NGM plates were seeded with <italic>Escherichia coli</italic> OP50 obtained from CGC that was grown in LB broth at 37°C for 18 hr shaking at 225 rpm. Plates with bacteria were dried for 48 hr before use.</p><p>For RNAi experiments, <italic>E. coli</italic> HT115 (DE3) bacteria obtained from the Ahringer and Vidal RNAi Library were used (<xref ref-type="bibr" rid="bib39">Kamath et al., 2003</xref>; <xref ref-type="bibr" rid="bib69">Rual et al., 2004</xref>). All RNAi clones were verified via sequencing (Eurofins). RNAi plates were prepared by cooling NGM to 55°C and supplementing with a final concentration of 50 μg/ml carbenicillin and 1 mM Isopropyl β-d-1-thiogalactopyranoside (IPTG). RNAi bacteria were inoculated with one colony of RNAi bacteria into LB with 50 μg/ml carbenicillin and were grown shaking overnight for 18 hr at 37° at 225 rpm.</p></sec><sec id="s4-3"><title>Post-developmental timing</title><p>To achieve synchronous nematode populations, day 1 adult nematodes were allowed to lay eggs for 2 hr on seeded NGM plates. For convenience, nematodes were developed at 25°C on <italic>E. coli</italic> OP50 until worms were visibly past the L4 stage (loss of crescent) but not yet gravid, approximately 45 hr for wild-type (although the time it takes for the worms to reach the young adult stage varies by strain). Nematodes were shifted to 20°C once they reached adulthood.</p></sec><sec id="s4-4"><title>RNAi treatment</title><p>For developmental treatments, synchronized eggs were moved onto plates seeded with RNAi bacteria and developed at 20°C for 72 hr. Nematodes were then either collected for analysis or for lifespans, remained on RNAi bacteria for the remainder of their life for survival analysis. For post-developmental treatments, synchronized eggs were developed on plates with <italic>E. coli</italic> OP50 at 25°C until the young adult stage and then transferred to RNAi plates at 20°C. Nematodes were collected after 48 hr for analysis or for lifespans, moved onto <italic>E. coli</italic> OP50 for the remainder of their life.</p></sec><sec id="s4-5"><title>Quantitative RT-PCR</title><p>Approximately 300 adult nematodes were collected; nematode pellets were resuspended in 300 μL RNA Lysis Buffer and frozen. Pellets was thawed, vortexed, and snap frozen three times. Zymo Research Quick-RNA MiniPrep kit was used to extract RNA.</p></sec><sec id="s4-6"><title>Lifespans</title><p>Day 1 adult nematodes were allowed to lay eggs for 2 hr on seeded NGM plates to obtain a synchronous aging population. 5-fluoro-2-deoxyuridine (FUdR) was omitted from plates due to its potentially confounding effects (<xref ref-type="bibr" rid="bib3">Angeli et al., 2013</xref>). Worms are transferred to freshly seeded bacterial plates every day for the first 7 days of adulthood and then as needed afterwards. Worms were scored as dead when they failed to respond to gentle prodding with a platinum wire. Worms that experienced matricide or bagging were censored.</p></sec><sec id="s4-7"><title>TMRM staining</title><p>Plates were prepared by spotting seeded NGM plates with a TMRM solution diluted in water to a final concentration of 0.1 μM in the plates. Water was used as a solvent control. Plates were allowed to dry for 24 hr before use. For developmental experiments, synchronized eggs were placed on plates for 72 hr and then nematodes were collected for analysis. For post-developmental experiments, young adult nematodes were placed on plates for 48 hr and then collected for analysis.</p></sec><sec id="s4-8"><title>CsA treatment</title><p>Plates were prepared by spotting seeded NGM plates with a CsA (stock solution in DMSO) solution diluted in 100% ethanol. Comparable amounts of DMSO and ethanol were used as solvent controls. Plates were allowed to dry for 24 hr before use. For developmental experiments, synchronized eggs were placed on plates for 72 hr and then nematodes were collected for analysis. For post-developmental experiments, young adult nematodes were placed on plates for 48 hr and then collected for analysis; for lifespans, worms were moved to regular NGM plates for the remainder of their life after 48 hr on drug-treated RNAi bacteria.</p></sec><sec id="s4-9"><title>Microscopy</title><p>Worms were anesthetized with 2 mM levamisole and mounted on 2% agarose pads on glass slides. Fluorescence micrographs of GFP and TMRM were taken using a Zeiss Imager A2 at 5× magnification with 600 ms exposure using the ZEN software. GFP expression was enhanced using the brightness/contrast tool in Photoshop. The same parameters were used for all images.</p><p>Confocal micrographs of mitochondrially targeted GFP and the cytosolic calcium sensor D3cpv (<xref ref-type="bibr" rid="bib78">Zhang et al., 2016</xref>) were taken using a Zeiss LSM780 laser scanning confocal microscope using a 63× Plan Apochromat NA1.4. To visualize outlines of mitochondria, Image Analyst MKII (Image Analyst Software, Novato, CA) was used. Selected rectangular regions of interest (ROIs) from the worm intestine were segmented and converted to outlines by a modification of the ‘Segment mitochondria’ pipeline. Emission ratio images of D3cpv were excited at 440 nm and captured at 450–490 nm and 520–560 nm and analyzed in Image Analyst MKII. Images were Wiener filtered, and the ratio of the 540 nm over the 470 nm channel, indicative of cytosolic calcium concentration, was calculated and showed in pseudo-color coding. Emission ratios were determined in ROIs in the posterior intestine by the Plot Ratio function.</p></sec><sec id="s4-10"><title>Western blot</title><p>Approximately 30–50 adult worms were collected in S-basal buffer. Supernatant was removed and nematodes were flash-frozen. Worms pellets were resuspended in 2% SDS sample buffer with 2.5% β−mercaptoethanol and samples were boiled for 10 min. Samples were subjected to SDS-PAGE using 4–12% SDS gels (Invitrogen) and transferred to Immun-Blot PVDF Membrane (Bio-Rad) using Bio-Rad western blot criterion apparatus. Membranes were blocked with 5% non-fat dry milk blocking solution; concentrations for antibodies were 1:1000 for primary antibodies and 1:2000 for secondary antibodies.</p></sec><sec id="s4-11"><title>Statistics</title><p>Significance between control and experimental groups was determined by using two-tailed Student’s <italic>t</italic>-test. Asterisks denote corresponding statistical significance: *p&lt;0.05; **p&lt;0.01; ***p&lt;0.0001. Error bars were generated using the standard error of the mean (SEM), typically from three pooled biological replicates. GraphPad Prism 7 was used to plot survival curves. Log rank (Mantel–Cox) test in Prism was used to determine significance between the control and experimental groups.</p></sec><sec id="s4-12"><title>GFP quantification</title><p>GFP intensity of worms was quantified using ImageJ 1.52A. The ‘integrated density’ of GFP expression and length of worms was measured using ImageJ tools. Integrated density value was normalized by number of worms and average length of worms. The final value is in arbitrary units.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank members of the Lithgow and Andersen labs for helpful discussion and advice on this research and the Buck Institute Morphology Department for their core services. <italic>C. elegans</italic> strains used in this work were provided by the Caenorhabditis Genetics Center (CGC), funded by the NIH Office of Research Infrastructure Programs (P40OD010440), and the Japanese National BioResource Project. The Y82E9BR.3 RNAi clone was a generous gift from Dr. Seung-Jae V Lee from the Seoul National University College of Medicine. This work was supported by NIH grants RFAG057358 and R01AG029631 and the Larry L. Hillblom Foundation.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Validation, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Validation, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con6"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-63453-transrepform-v1.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Data generated or analyzed during this study are included in the manuscript and supporting files. Worm strains generated from this study will be deposited and available via the Caenorhabditis Genetics Center.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alavian</surname> <given-names>KN</given-names></name><name><surname>Beutner</surname> <given-names>G</given-names></name><name><surname>Lazrove</surname> <given-names>E</given-names></name><name><surname>Sacchetti</surname> <given-names>S</given-names></name><name><surname>Park</surname> <given-names>HA</given-names></name><name><surname>Licznerski</surname> <given-names>P</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Nabili</surname> <given-names>P</given-names></name><name><surname>Hockensmith</surname> <given-names>K</given-names></name><name><surname>Graham</surname> <given-names>M</given-names></name><name><surname>Porter</surname> <given-names>GA</given-names></name><name><surname>Jonas</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore</article-title><source>PNAS</source><volume>111</volume><fpage>10580</fpage><lpage>10585</lpage><pub-id pub-id-type="doi">10.1073/pnas.1401591111</pub-id><pub-id pub-id-type="pmid">24979777</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amodeo</surname> <given-names>GF</given-names></name><name><surname>Lee</surname> <given-names>BY</given-names></name><name><surname>Krilyuk</surname> <given-names>N</given-names></name><name><surname>Filice</surname> <given-names>CT</given-names></name><name><surname>Valyuk</surname> <given-names>D</given-names></name><name><surname>Otzen</surname> <given-names>DE</given-names></name><name><surname>Noskov</surname> <given-names>S</given-names></name><name><surname>Leonenko</surname> <given-names>Z</given-names></name><name><surname>Pavlov</surname> <given-names>EV</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>C subunit of the ATP synthase is an amyloidogenic calcium dependent channel-forming peptide with possible implications in mitochondrial permeability transition</article-title><source>Scientific Reports</source><volume>11</volume><elocation-id>8744</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-021-88157-z</pub-id><pub-id pub-id-type="pmid">33888826</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angeli</surname> <given-names>S</given-names></name><name><surname>Klang</surname> <given-names>I</given-names></name><name><surname>Sivapatham</surname> <given-names>R</given-names></name><name><surname>Mark</surname> <given-names>K</given-names></name><name><surname>Zucker</surname> <given-names>D</given-names></name><name><surname>Bhaumik</surname> <given-names>D</given-names></name><name><surname>Lithgow</surname> <given-names>GJ</given-names></name><name><surname>Andersen</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A DNA synthesis inhibitor is protective against proteotoxic stressors via modulation of fertility pathways in Caenorhabditis elegans</article-title><source>Aging</source><volume>5</volume><fpage>759</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.18632/aging.100605</pub-id><pub-id pub-id-type="pmid">24123581</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angeli</surname> <given-names>S</given-names></name><name><surname>Barhydt</surname> <given-names>T</given-names></name><name><surname>Jacobs</surname> <given-names>R</given-names></name><name><surname>Killilea</surname> <given-names>DW</given-names></name><name><surname>Lithgow</surname> <given-names>GJ</given-names></name><name><surname>Andersen</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Manganese disturbs metal and protein homeostasis in Caenorhabditis elegans</article-title><source>Metallomics</source><volume>6</volume><fpage>1816</fpage><lpage>1823</lpage><pub-id pub-id-type="doi">10.1039/C4MT00168K</pub-id><pub-id pub-id-type="pmid">25057947</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antoniel</surname> <given-names>M</given-names></name><name><surname>Jones</surname> <given-names>K</given-names></name><name><surname>Antonucci</surname> <given-names>S</given-names></name><name><surname>Spolaore</surname> <given-names>B</given-names></name><name><surname>Fogolari</surname> <given-names>F</given-names></name><name><surname>Petronilli</surname> <given-names>V</given-names></name><name><surname>Giorgio</surname> <given-names>V</given-names></name><name><surname>Carraro</surname> <given-names>M</given-names></name><name><surname>Di Lisa</surname> <given-names>F</given-names></name><name><surname>Forte</surname> <given-names>M</given-names></name><name><surname>Szabó</surname> <given-names>I</given-names></name><name><surname>Lippe</surname> <given-names>G</given-names></name><name><surname>Bernardi</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The unique histidine in OSCP subunit of F-ATP synthase mediates inhibition of the permeability transition pore by acidic pH</article-title><source>EMBO Reports</source><volume>19</volume><fpage>257</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.15252/embr.201744705</pub-id><pub-id pub-id-type="pmid">29217657</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azarashvili</surname> <given-names>T</given-names></name><name><surname>Odinokova</surname> <given-names>I</given-names></name><name><surname>Bakunts</surname> <given-names>A</given-names></name><name><surname>Ternovsky</surname> <given-names>V</given-names></name><name><surname>Krestinina</surname> <given-names>O</given-names></name><name><surname>Tyynelä</surname> <given-names>J</given-names></name><name><surname>Saris</surname> <given-names>NE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Potential role of subunit c of F0F1-ATPase and subunit c of storage body in the mitochondrial permeability transition. Effect of the phosphorylation status of subunit c on pore opening</article-title><source>Cell Calcium</source><volume>55</volume><fpage>69</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.ceca.2013.12.002</pub-id><pub-id pub-id-type="pmid">24380588</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baines</surname> <given-names>CP</given-names></name><name><surname>Kaiser</surname> <given-names>RA</given-names></name><name><surname>Purcell</surname> <given-names>NH</given-names></name><name><surname>Blair</surname> <given-names>NS</given-names></name><name><surname>Osinska</surname> <given-names>H</given-names></name><name><surname>Hambleton</surname> <given-names>MA</given-names></name><name><surname>Brunskill</surname> <given-names>EW</given-names></name><name><surname>Sayen</surname> <given-names>MR</given-names></name><name><surname>Gottlieb</surname> <given-names>RA</given-names></name><name><surname>Dorn</surname> <given-names>GW</given-names></name><name><surname>Robbins</surname> <given-names>J</given-names></name><name><surname>Molkentin</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death</article-title><source>Nature</source><volume>434</volume><fpage>658</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1038/nature03434</pub-id><pub-id pub-id-type="pmid">15800627</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname> <given-names>BM</given-names></name><name><surname>Nargund</surname> <given-names>AM</given-names></name><name><surname>Sun</surname> <given-names>T</given-names></name><name><surname>Haynes</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Protective coupling of mitochondrial function and protein synthesis via the eIF2α kinase GCN-2</article-title><source>PLOS Genetics</source><volume>8</volume><elocation-id>e1002760</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002760</pub-id><pub-id pub-id-type="pmid">22719267</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basso</surname> <given-names>E</given-names></name><name><surname>Fante</surname> <given-names>L</given-names></name><name><surname>Fowlkes</surname> <given-names>J</given-names></name><name><surname>Petronilli</surname> <given-names>V</given-names></name><name><surname>Forte</surname> <given-names>MA</given-names></name><name><surname>Bernardi</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D</article-title><source>Journal of Biological Chemistry</source><volume>280</volume><fpage>18558</fpage><lpage>18561</lpage><pub-id pub-id-type="doi">10.1074/jbc.C500089200</pub-id><pub-id pub-id-type="pmid">15792954</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname> <given-names>JS</given-names></name><name><surname>Mufson</surname> <given-names>EJ</given-names></name><name><surname>Counts</surname> <given-names>SE</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>Evidence for mitochondrial UPR gene activation in familial and sporadic alzheimer's Disease</article-title><source>Current Alzheimer Research</source><volume>13</volume><fpage>610</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.2174/1567205013666151221145445</pub-id><pub-id pub-id-type="pmid">26687188</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname> <given-names>SJ</given-names></name><name><surname>Guo</surname> <given-names>L</given-names></name><name><surname>Phensy</surname> <given-names>A</given-names></name><name><surname>Tian</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Tandon</surname> <given-names>N</given-names></name><name><surname>Gauba</surname> <given-names>E</given-names></name><name><surname>Lu</surname> <given-names>L</given-names></name><name><surname>Pascual</surname> <given-names>JM</given-names></name><name><surname>Kroener</surname> <given-names>S</given-names></name><name><surname>Du</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer's disease</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11483</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11483</pub-id><pub-id pub-id-type="pmid">27151236</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname> <given-names>CF</given-names></name><name><surname>Vander Wende</surname> <given-names>H</given-names></name><name><surname>Simko</surname> <given-names>M</given-names></name><name><surname>Klum</surname> <given-names>S</given-names></name><name><surname>Barfield</surname> <given-names>S</given-names></name><name><surname>Choi</surname> <given-names>H</given-names></name><name><surname>Pineda</surname> <given-names>VV</given-names></name><name><surname>Kaeberlein</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Activation of the mitochondrial unfolded protein response does not predict longevity in Caenorhabditis elegans</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>3483</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms4483</pub-id><pub-id pub-id-type="pmid">24662282</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergeaud</surname> <given-names>M</given-names></name><name><surname>Mathieu</surname> <given-names>L</given-names></name><name><surname>Guillaume</surname> <given-names>A</given-names></name><name><surname>Moll</surname> <given-names>UM</given-names></name><name><surname>Mignotte</surname> <given-names>B</given-names></name><name><surname>Le Floch</surname> <given-names>N</given-names></name><name><surname>Vayssière</surname> <given-names>JL</given-names></name><name><surname>Rincheval</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mitochondrial p53 mediates a transcription-independent regulation of cell respiration and interacts with the mitochondrial F₁F0-ATP synthase</article-title><source>Cell Cycle</source><volume>12</volume><fpage>2781</fpage><lpage>2793</lpage><pub-id pub-id-type="doi">10.4161/cc.25870</pub-id><pub-id pub-id-type="pmid">23966169</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernardi</surname> <given-names>P</given-names></name><name><surname>Di Lisa</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>78</volume><fpage>100</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2014.09.023</pub-id><pub-id pub-id-type="pmid">25268651</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonora</surname> <given-names>M</given-names></name><name><surname>Bononi</surname> <given-names>A</given-names></name><name><surname>De Marchi</surname> <given-names>E</given-names></name><name><surname>Giorgi</surname> <given-names>C</given-names></name><name><surname>Lebiedzinska</surname> <given-names>M</given-names></name><name><surname>Marchi</surname> <given-names>S</given-names></name><name><surname>Patergnani</surname> <given-names>S</given-names></name><name><surname>Rimessi</surname> <given-names>A</given-names></name><name><surname>Suski</surname> <given-names>JM</given-names></name><name><surname>Wojtala</surname> <given-names>A</given-names></name><name><surname>Wieckowski</surname> <given-names>MR</given-names></name><name><surname>Kroemer</surname> <given-names>G</given-names></name><name><surname>Galluzzi</surname> <given-names>L</given-names></name><name><surname>Pinton</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition</article-title><source>Cell Cycle</source><volume>12</volume><fpage>674</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.4161/cc.23599</pub-id><pub-id pub-id-type="pmid">23343770</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonora</surname> <given-names>M</given-names></name><name><surname>Morganti</surname> <given-names>C</given-names></name><name><surname>Morciano</surname> <given-names>G</given-names></name><name><surname>Pedriali</surname> <given-names>G</given-names></name><name><surname>Lebiedzinska-Arciszewska</surname> <given-names>M</given-names></name><name><surname>Aquila</surname> <given-names>G</given-names></name><name><surname>Giorgi</surname> <given-names>C</given-names></name><name><surname>Rizzo</surname> <given-names>P</given-names></name><name><surname>Campo</surname> <given-names>G</given-names></name><name><surname>Ferrari</surname> <given-names>R</given-names></name><name><surname>Kroemer</surname> <given-names>G</given-names></name><name><surname>Wieckowski</surname> <given-names>MR</given-names></name><name><surname>Galluzzi</surname> <given-names>L</given-names></name><name><surname>Pinton</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mitochondrial permeability transition involves dissociation of F<sub>1</sub>F<sub>O</sub> ATP synthase dimers and C-ring conformation</article-title><source>EMBO Reports</source><volume>18</volume><fpage>1077</fpage><lpage>1089</lpage><pub-id pub-id-type="doi">10.15252/embr.201643602</pub-id><pub-id pub-id-type="pmid">28566520</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carraro</surname> <given-names>M</given-names></name><name><surname>Giorgio</surname> <given-names>V</given-names></name><name><surname>Šileikytė</surname> <given-names>J</given-names></name><name><surname>Sartori</surname> <given-names>G</given-names></name><name><surname>Forte</surname> <given-names>M</given-names></name><name><surname>Lippe</surname> <given-names>G</given-names></name><name><surname>Zoratti</surname> <given-names>M</given-names></name><name><surname>Szabò</surname> <given-names>I</given-names></name><name><surname>Bernardi</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Channel formation by yeast F-ATP synthase and the role of dimerization in the mitochondrial permeability transition</article-title><source>Journal of Biological Chemistry</source><volume>289</volume><fpage>15980</fpage><lpage>15985</lpage><pub-id pub-id-type="doi">10.1074/jbc.C114.559633</pub-id><pub-id pub-id-type="pmid">24790105</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carraro</surname> <given-names>M</given-names></name><name><surname>Checchetto</surname> <given-names>V</given-names></name><name><surname>Szabó</surname> <given-names>I</given-names></name><name><surname>Bernardi</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>F-ATP synthase and the permeability transition pore: fewer doubts, more certainties</article-title><source>FEBS Letters</source><volume>593</volume><fpage>1542</fpage><lpage>1553</lpage><pub-id pub-id-type="doi">10.1002/1873-3468.13485</pub-id><pub-id pub-id-type="pmid">31197821</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrer</surname> <given-names>A</given-names></name><name><surname>Tommasin</surname> <given-names>L</given-names></name><name><surname>Šileikytė</surname> <given-names>J</given-names></name><name><surname>Ciscato</surname> <given-names>F</given-names></name><name><surname>Filadi</surname> <given-names>R</given-names></name><name><surname>Urbani</surname> <given-names>A</given-names></name><name><surname>Forte</surname> <given-names>M</given-names></name><name><surname>Rasola</surname> <given-names>A</given-names></name><name><surname>Szabò</surname> <given-names>I</given-names></name><name><surname>Carraro</surname> <given-names>M</given-names></name><name><surname>Bernardi</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Defining the molecular mechanisms of the mitochondrial permeability transition through genetic manipulation of F-ATP synthase</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>4835</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-25161-x</pub-id><pub-id pub-id-type="pmid">34376679</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname> <given-names>J</given-names></name><name><surname>He</surname> <given-names>J</given-names></name><name><surname>Ding</surname> <given-names>S</given-names></name><name><surname>Fearnley</surname> <given-names>IM</given-names></name><name><surname>Walker</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Persistence of the permeability transition pore in human mitochondria devoid of an assembled ATP synthase</article-title><source>PNAS</source><volume>116</volume><fpage>12816</fpage><lpage>12821</lpage><pub-id pub-id-type="doi">10.1073/pnas.1904005116</pub-id><pub-id pub-id-type="pmid">31213546</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costantini</surname> <given-names>P</given-names></name><name><surname>Petronilli</surname> <given-names>V</given-names></name><name><surname>Colonna</surname> <given-names>R</given-names></name><name><surname>Bernardi</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>On the effects of paraquat on isolated mitochondria. Evidence that paraquat causes opening of the cyclosporin A-sensitive permeability transition pore synergistically with nitric oxide</article-title><source>Toxicology</source><volume>99</volume><fpage>77</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/0300-483X(94)02997-9</pub-id><pub-id pub-id-type="pmid">7539163</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daum</surname> <given-names>B</given-names></name><name><surname>Walter</surname> <given-names>A</given-names></name><name><surname>Horst</surname> <given-names>A</given-names></name><name><surname>Osiewacz</surname> <given-names>HD</given-names></name><name><surname>Kühlbrandt</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Age-dependent dissociation of ATP synthase dimers and loss of inner-membrane cristae in mitochondria</article-title><source>PNAS</source><volume>110</volume><fpage>15301</fpage><lpage>15306</lpage><pub-id pub-id-type="doi">10.1073/pnas.1305462110</pub-id><pub-id pub-id-type="pmid">24006361</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dillin</surname> <given-names>A</given-names></name><name><surname>Hsu</surname> <given-names>AL</given-names></name><name><surname>Arantes-Oliveira</surname> <given-names>N</given-names></name><name><surname>Lehrer-Graiwer</surname> <given-names>J</given-names></name><name><surname>Hsin</surname> <given-names>H</given-names></name><name><surname>Fraser</surname> <given-names>AG</given-names></name><name><surname>Kamath</surname> <given-names>RS</given-names></name><name><surname>Ahringer</surname> <given-names>J</given-names></name><name><surname>Kenyon</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Rates of behavior and aging specified by mitochondrial function during development</article-title><source>Science</source><volume>298</volume><fpage>2398</fpage><lpage>2401</lpage><pub-id pub-id-type="doi">10.1126/science.1077780</pub-id><pub-id pub-id-type="pmid">12471266</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durieux</surname> <given-names>J</given-names></name><name><surname>Wolff</surname> <given-names>S</given-names></name><name><surname>Dillin</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The cell-non-autonomous nature of electron transport chain-mediated longevity</article-title><source>Cell</source><volume>144</volume><fpage>79</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.12.016</pub-id><pub-id pub-id-type="pmid">21215371</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farina</surname> <given-names>F</given-names></name><name><surname>Alberti</surname> <given-names>A</given-names></name><name><surname>Breuil</surname> <given-names>N</given-names></name><name><surname>Bolotin-Fukuhara</surname> <given-names>M</given-names></name><name><surname>Pinto</surname> <given-names>M</given-names></name><name><surname>Culetto</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Differential expression pattern of the four mitochondrial adenine nucleotide transporter ant genes and their roles during the development of Caenorhabditis elegans</article-title><source>Developmental Dynamics</source><volume>237</volume><fpage>1668</fpage><lpage>1681</lpage><pub-id pub-id-type="doi">10.1002/dvdy.21578</pub-id><pub-id pub-id-type="pmid">18498090</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukasawa</surname> <given-names>Y</given-names></name><name><surname>Tsuji</surname> <given-names>J</given-names></name><name><surname>Fu</surname> <given-names>SC</given-names></name><name><surname>Tomii</surname> <given-names>K</given-names></name><name><surname>Horton</surname> <given-names>P</given-names></name><name><surname>Imai</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>MitoFates: improved prediction of mitochondrial targeting sequences and their cleavage sites</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>14</volume><fpage>1113</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1074/mcp.M114.043083</pub-id><pub-id pub-id-type="pmid">25670805</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauba</surname> <given-names>E</given-names></name><name><surname>Guo</surname> <given-names>L</given-names></name><name><surname>Du</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cyclophilin D promotes brain mitochondrial F1FO ATP synthase dysfunction in aging mice</article-title><source>Journal of Alzheimer's Disease</source><volume>55</volume><fpage>1351</fpage><lpage>1362</lpage><pub-id pub-id-type="doi">10.3233/JAD-160822</pub-id><pub-id pub-id-type="pmid">27834780</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giorgio</surname> <given-names>V</given-names></name><name><surname>Bisetto</surname> <given-names>E</given-names></name><name><surname>Soriano</surname> <given-names>ME</given-names></name><name><surname>Dabbeni-Sala</surname> <given-names>F</given-names></name><name><surname>Basso</surname> <given-names>E</given-names></name><name><surname>Petronilli</surname> <given-names>V</given-names></name><name><surname>Forte</surname> <given-names>MA</given-names></name><name><surname>Bernardi</surname> <given-names>P</given-names></name><name><surname>Lippe</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex</article-title><source>Journal of Biological Chemistry</source><volume>284</volume><fpage>33982</fpage><lpage>33988</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.020115</pub-id><pub-id pub-id-type="pmid">19801635</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giorgio</surname> <given-names>V</given-names></name><name><surname>von Stockum</surname> <given-names>S</given-names></name><name><surname>Antoniel</surname> <given-names>M</given-names></name><name><surname>Fabbro</surname> <given-names>A</given-names></name><name><surname>Fogolari</surname> <given-names>F</given-names></name><name><surname>Forte</surname> <given-names>M</given-names></name><name><surname>Glick</surname> <given-names>GD</given-names></name><name><surname>Petronilli</surname> <given-names>V</given-names></name><name><surname>Zoratti</surname> <given-names>M</given-names></name><name><surname>Szabó</surname> <given-names>I</given-names></name><name><surname>Lippe</surname> <given-names>G</given-names></name><name><surname>Bernardi</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dimers of mitochondrial ATP synthase form the permeability transition pore</article-title><source>PNAS</source><volume>110</volume><fpage>5887</fpage><lpage>5892</lpage><pub-id pub-id-type="doi">10.1073/pnas.1217823110</pub-id><pub-id pub-id-type="pmid">23530243</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giorgio</surname> <given-names>V</given-names></name><name><surname>Burchell</surname> <given-names>V</given-names></name><name><surname>Schiavone</surname> <given-names>M</given-names></name><name><surname>Bassot</surname> <given-names>C</given-names></name><name><surname>Minervini</surname> <given-names>G</given-names></name><name><surname>Petronilli</surname> <given-names>V</given-names></name><name><surname>Argenton</surname> <given-names>F</given-names></name><name><surname>Forte</surname> <given-names>M</given-names></name><name><surname>Tosatto</surname> <given-names>S</given-names></name><name><surname>Lippe</surname> <given-names>G</given-names></name><name><surname>Bernardi</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ca<sup>2+</sup> binding to F-ATP synthase β subunit triggers the mitochondrial permeability transition</article-title><source>EMBO Reports</source><volume>18</volume><fpage>1065</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.15252/embr.201643354</pub-id><pub-id pub-id-type="pmid">28507163</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>L</given-names></name><name><surname>Carraro</surname> <given-names>M</given-names></name><name><surname>Carrer</surname> <given-names>A</given-names></name><name><surname>Minervini</surname> <given-names>G</given-names></name><name><surname>Urbani</surname> <given-names>A</given-names></name><name><surname>Masgras</surname> <given-names>I</given-names></name><name><surname>Tosatto</surname> <given-names>SCE</given-names></name><name><surname>Szabò</surname> <given-names>I</given-names></name><name><surname>Bernardi</surname> <given-names>P</given-names></name><name><surname>Lippe</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Arg-8 of yeast subunit e contributes to the stability of F-ATP synthase dimers and to the generation of the full-conductance mitochondrial megachannel</article-title><source>Journal of Biological Chemistry</source><volume>294</volume><fpage>10987</fpage><lpage>10997</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA119.008775</pub-id><pub-id pub-id-type="pmid">31160339</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>K</given-names></name><name><surname>Gao</surname> <given-names>X</given-names></name><name><surname>Zhou</surname> <given-names>Z</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Yang</surname> <given-names>K</given-names></name><name><surname>Huang</surname> <given-names>K</given-names></name><name><surname>Yang</surname> <given-names>Q</given-names></name><name><surname>Long</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Sustained oligomycin sensitivity conferring protein expression in cardiomyocytes protects against cardiac hypertrophy induced by pressure overload via improving mitochondrial function</article-title><source>Human Gene Therapy</source><volume>31</volume><fpage>1178</fpage><lpage>1189</lpage><pub-id pub-id-type="doi">10.1089/hum.2020.004</pub-id><pub-id pub-id-type="pmid">32787458</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haynes</surname> <given-names>CM</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Blais</surname> <given-names>SP</given-names></name><name><surname>Neubert</surname> <given-names>TA</given-names></name><name><surname>Ron</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans</article-title><source>Molecular Cell</source><volume>37</volume><fpage>529</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.01.015</pub-id><pub-id pub-id-type="pmid">20188671</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>J</given-names></name><name><surname>Carroll</surname> <given-names>J</given-names></name><name><surname>Ding</surname> <given-names>S</given-names></name><name><surname>Fearnley</surname> <given-names>IM</given-names></name><name><surname>Walker</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>Permeability transition in human mitochondria persists in the absence of peripheral stalk subunits of ATP synthase</article-title><source>PNAS</source><volume>114</volume><fpage>9086</fpage><lpage>9091</lpage><pub-id pub-id-type="doi">10.1073/pnas.1711201114</pub-id><pub-id pub-id-type="pmid">28784775</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>J</given-names></name><name><surname>Ford</surname> <given-names>HC</given-names></name><name><surname>Carroll</surname> <given-names>J</given-names></name><name><surname>Ding</surname> <given-names>S</given-names></name><name><surname>Fearnley</surname> <given-names>IM</given-names></name><name><surname>Walker</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>Persistence of the mitochondrial permeability transition in the absence of subunit c of human ATP synthase</article-title><source>PNAS</source><volume>114</volume><fpage>3409</fpage><lpage>3414</lpage><pub-id pub-id-type="doi">10.1073/pnas.1702357114</pub-id><pub-id pub-id-type="pmid">28289229</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>L</given-names></name><name><surname>Lemasters</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function?</article-title><source>FEBS Letters</source><volume>512</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(01)03314-2</pub-id><pub-id pub-id-type="pmid">11852041</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houtkooper</surname> <given-names>RH</given-names></name><name><surname>Mouchiroud</surname> <given-names>L</given-names></name><name><surname>Ryu</surname> <given-names>D</given-names></name><name><surname>Moullan</surname> <given-names>N</given-names></name><name><surname>Katsyuba</surname> <given-names>E</given-names></name><name><surname>Knott</surname> <given-names>G</given-names></name><name><surname>Williams</surname> <given-names>RW</given-names></name><name><surname>Auwerx</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mitonuclear protein imbalance as a conserved longevity mechanism</article-title><source>Nature</source><volume>497</volume><fpage>451</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1038/nature12188</pub-id><pub-id pub-id-type="pmid">23698443</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iurlaro</surname> <given-names>R</given-names></name><name><surname>Muñoz-Pinedo</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cell death induced by endoplasmic reticulum stress</article-title><source>The FEBS Journal</source><volume>283</volume><fpage>2640</fpage><lpage>2652</lpage><pub-id pub-id-type="doi">10.1111/febs.13598</pub-id><pub-id pub-id-type="pmid">26587781</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamath</surname> <given-names>RS</given-names></name><name><surname>Fraser</surname> <given-names>AG</given-names></name><name><surname>Dong</surname> <given-names>Y</given-names></name><name><surname>Poulin</surname> <given-names>G</given-names></name><name><surname>Durbin</surname> <given-names>R</given-names></name><name><surname>Gotta</surname> <given-names>M</given-names></name><name><surname>Kanapin</surname> <given-names>A</given-names></name><name><surname>Le Bot</surname> <given-names>N</given-names></name><name><surname>Moreno</surname> <given-names>S</given-names></name><name><surname>Sohrmann</surname> <given-names>M</given-names></name><name><surname>Welchman</surname> <given-names>DP</given-names></name><name><surname>Zipperlen</surname> <given-names>P</given-names></name><name><surname>Ahringer</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Systematic functional analysis of the Caenorhabditis elegans genome using RNAi</article-title><source>Nature</source><volume>421</volume><fpage>231</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1038/nature01278</pub-id><pub-id pub-id-type="pmid">12529635</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karch</surname> <given-names>J</given-names></name><name><surname>Bround</surname> <given-names>MJ</given-names></name><name><surname>Khalil</surname> <given-names>H</given-names></name><name><surname>Sargent</surname> <given-names>MA</given-names></name><name><surname>Latchman</surname> <given-names>N</given-names></name><name><surname>Terada</surname> <given-names>N</given-names></name><name><surname>Peixoto</surname> <given-names>PM</given-names></name><name><surname>Molkentin</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD</article-title><source>Science Advances</source><volume>5</volume><elocation-id>eaaw4597</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aaw4597</pub-id><pub-id pub-id-type="pmid">31489369</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufman</surname> <given-names>DM</given-names></name><name><surname>Crowder</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mitochondrial proteostatic collapse leads to hypoxic injury</article-title><source>Current Biology</source><volume>25</volume><fpage>2171</fpage><lpage>2176</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2015.06.062</pub-id><pub-id pub-id-type="pmid">26234215</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>HE</given-names></name><name><surname>Grant</surname> <given-names>AR</given-names></name><name><surname>Simic</surname> <given-names>MS</given-names></name><name><surname>Kohnz</surname> <given-names>RA</given-names></name><name><surname>Nomura</surname> <given-names>DK</given-names></name><name><surname>Durieux</surname> <given-names>J</given-names></name><name><surname>Riera</surname> <given-names>CE</given-names></name><name><surname>Sanchez</surname> <given-names>M</given-names></name><name><surname>Kapernick</surname> <given-names>E</given-names></name><name><surname>Wolff</surname> <given-names>S</given-names></name><name><surname>Dillin</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lipid biosynthesis coordinates a Mitochondrial-to-Cytosolic stress response</article-title><source>Cell</source><volume>166</volume><fpage>1539</fpage><lpage>1552</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.08.027</pub-id><pub-id pub-id-type="pmid">27610574</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwong</surname> <given-names>JQ</given-names></name><name><surname>Molkentin</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Physiological and pathological roles of the mitochondrial permeability transition pore in the heart</article-title><source>Cell Metabolism</source><volume>21</volume><fpage>206</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2014.12.001</pub-id><pub-id pub-id-type="pmid">25651175</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labbadia</surname> <given-names>J</given-names></name><name><surname>Morimoto</surname> <given-names>RI</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Repression of the heat shock response is a programmed event at the onset of reproduction</article-title><source>Molecular Cell</source><volume>59</volume><fpage>639</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.06.027</pub-id><pub-id pub-id-type="pmid">26212459</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Licznerski</surname> <given-names>P</given-names></name><name><surname>Park</surname> <given-names>HA</given-names></name><name><surname>Rolyan</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>R</given-names></name><name><surname>Mnatsakanyan</surname> <given-names>N</given-names></name><name><surname>Miranda</surname> <given-names>P</given-names></name><name><surname>Graham</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Cruz-Reyes</surname> <given-names>N</given-names></name><name><surname>Mehta</surname> <given-names>N</given-names></name><name><surname>Sohail</surname> <given-names>S</given-names></name><name><surname>Salcedo</surname> <given-names>J</given-names></name><name><surname>Song</surname> <given-names>E</given-names></name><name><surname>Effman</surname> <given-names>C</given-names></name><name><surname>Effman</surname> <given-names>S</given-names></name><name><surname>Brandao</surname> <given-names>L</given-names></name><name><surname>Xu</surname> <given-names>GN</given-names></name><name><surname>Braker</surname> <given-names>A</given-names></name><name><surname>Gribkoff</surname> <given-names>VK</given-names></name><name><surname>Levy</surname> <given-names>RJ</given-names></name><name><surname>Jonas</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ATP synthase c-Subunit leak causes aberrant cellular metabolism in fragile X syndrome</article-title><source>Cell</source><volume>182</volume><fpage>1170</fpage><lpage>1185</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.07.008</pub-id><pub-id pub-id-type="pmid">32795412</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>YF</given-names></name><name><surname>Schulz</surname> <given-names>AM</given-names></name><name><surname>Pellegrino</surname> <given-names>MW</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Shaham</surname> <given-names>S</given-names></name><name><surname>Haynes</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Maintenance and propagation of a deleterious mitochondrial genome by the mitochondrial unfolded protein response</article-title><source>Nature</source><volume>533</volume><fpage>416</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1038/nature17989</pub-id><pub-id pub-id-type="pmid">27135930</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Farmer</surname> <given-names>JD</given-names></name><name><surname>Lane</surname> <given-names>WS</given-names></name><name><surname>Friedman</surname> <given-names>J</given-names></name><name><surname>Weissman</surname> <given-names>I</given-names></name><name><surname>Schreiber</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes</article-title><source>Cell</source><volume>66</volume><fpage>807</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(91)90124-H</pub-id><pub-id pub-id-type="pmid">1715244</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludtmann</surname> <given-names>MHR</given-names></name><name><surname>Angelova</surname> <given-names>PR</given-names></name><name><surname>Horrocks</surname> <given-names>MH</given-names></name><name><surname>Choi</surname> <given-names>ML</given-names></name><name><surname>Rodrigues</surname> <given-names>M</given-names></name><name><surname>Baev</surname> <given-names>AY</given-names></name><name><surname>Berezhnov</surname> <given-names>AV</given-names></name><name><surname>Yao</surname> <given-names>Z</given-names></name><name><surname>Little</surname> <given-names>D</given-names></name><name><surname>Banushi</surname> <given-names>B</given-names></name><name><surname>Al-Menhali</surname> <given-names>AS</given-names></name><name><surname>Ranasinghe</surname> <given-names>RT</given-names></name><name><surname>Whiten</surname> <given-names>DR</given-names></name><name><surname>Yapom</surname> <given-names>R</given-names></name><name><surname>Dolt</surname> <given-names>KS</given-names></name><name><surname>Devine</surname> <given-names>MJ</given-names></name><name><surname>Gissen</surname> <given-names>P</given-names></name><name><surname>Kunath</surname> <given-names>T</given-names></name><name><surname>Jaganjac</surname> <given-names>M</given-names></name><name><surname>Pavlov</surname> <given-names>EV</given-names></name><name><surname>Klenerman</surname> <given-names>D</given-names></name><name><surname>Abramov</surname> <given-names>AY</given-names></name><name><surname>Gandhi</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>2293</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-04422-2</pub-id><pub-id pub-id-type="pmid">29895861</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname> <given-names>BA</given-names></name><name><surname>Petersen</surname> <given-names>DA</given-names></name><name><surname>Gaeta</surname> <given-names>AL</given-names></name><name><surname>Stanley</surname> <given-names>SP</given-names></name><name><surname>Caldwell</surname> <given-names>GA</given-names></name><name><surname>Caldwell</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dysregulation of the mitochondrial unfolded protein response induces Non-Apoptotic dopaminergic neurodegeneration in <italic>C. elegans</italic> Models of Parkinson's Disease</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>11085</fpage><lpage>11100</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1294-17.2017</pub-id><pub-id pub-id-type="pmid">29030433</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merkwirth</surname> <given-names>C</given-names></name><name><surname>Jovaisaite</surname> <given-names>V</given-names></name><name><surname>Durieux</surname> <given-names>J</given-names></name><name><surname>Matilainen</surname> <given-names>O</given-names></name><name><surname>Jordan</surname> <given-names>SD</given-names></name><name><surname>Quiros</surname> <given-names>PM</given-names></name><name><surname>Steffen</surname> <given-names>KK</given-names></name><name><surname>Williams</surname> <given-names>EG</given-names></name><name><surname>Mouchiroud</surname> <given-names>L</given-names></name><name><surname>Tronnes</surname> <given-names>SU</given-names></name><name><surname>Murillo</surname> <given-names>V</given-names></name><name><surname>Wolff</surname> <given-names>SC</given-names></name><name><surname>Shaw</surname> <given-names>RJ</given-names></name><name><surname>Auwerx</surname> <given-names>J</given-names></name><name><surname>Dillin</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Two conserved histone demethylases regulate mitochondrial Stress-Induced longevity</article-title><source>Cell</source><volume>165</volume><fpage>1209</fpage><lpage>1223</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.04.012</pub-id><pub-id pub-id-type="pmid">27133168</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mnatsakanyan</surname> <given-names>N</given-names></name><name><surname>Llaguno</surname> <given-names>MC</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Yan</surname> <given-names>Y</given-names></name><name><surname>Weber</surname> <given-names>J</given-names></name><name><surname>Sigworth</surname> <given-names>FJ</given-names></name><name><surname>Jonas</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A mitochondrial megachannel resides in monomeric F<sub>1</sub>F<sub>0</sub> ATP synthase</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>5823</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-13766-2</pub-id><pub-id pub-id-type="pmid">31862883</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mnatsakanyan</surname> <given-names>N</given-names></name><name><surname>Jonas</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ATP synthase c-subunit ring as the channel of mitochondrial permeability transition: Regulator of metabolism in development and degeneration</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>144</volume><fpage>109</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2020.05.013</pub-id><pub-id pub-id-type="pmid">32461058</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morciano</surname> <given-names>G</given-names></name><name><surname>Pedriali</surname> <given-names>G</given-names></name><name><surname>Bonora</surname> <given-names>M</given-names></name><name><surname>Pavasini</surname> <given-names>R</given-names></name><name><surname>Mikus</surname> <given-names>E</given-names></name><name><surname>Calvi</surname> <given-names>S</given-names></name><name><surname>Bovolenta</surname> <given-names>M</given-names></name><name><surname>Lebiedzinska-Arciszewska</surname> <given-names>M</given-names></name><name><surname>Pinotti</surname> <given-names>M</given-names></name><name><surname>Albertini</surname> <given-names>A</given-names></name><name><surname>Wieckowski</surname> <given-names>MR</given-names></name><name><surname>Giorgi</surname> <given-names>C</given-names></name><name><surname>Ferrari</surname> <given-names>R</given-names></name><name><surname>Galluzzi</surname> <given-names>L</given-names></name><name><surname>Campo</surname> <given-names>G</given-names></name><name><surname>Pinton</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients</article-title><source>Cell Reports</source><volume>35</volume><elocation-id>108983</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.108983</pub-id><pub-id pub-id-type="pmid">33852870</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouchiroud</surname> <given-names>L</given-names></name><name><surname>Houtkooper</surname> <given-names>RH</given-names></name><name><surname>Moullan</surname> <given-names>N</given-names></name><name><surname>Katsyuba</surname> <given-names>E</given-names></name><name><surname>Ryu</surname> <given-names>D</given-names></name><name><surname>Cantó</surname> <given-names>C</given-names></name><name><surname>Mottis</surname> <given-names>A</given-names></name><name><surname>Jo</surname> <given-names>YS</given-names></name><name><surname>Viswanathan</surname> <given-names>M</given-names></name><name><surname>Schoonjans</surname> <given-names>K</given-names></name><name><surname>Guarente</surname> <given-names>L</given-names></name><name><surname>Auwerx</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The NAD(+)/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling</article-title><source>Cell</source><volume>154</volume><fpage>430</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.06.016</pub-id><pub-id pub-id-type="pmid">23870130</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Münch</surname> <given-names>C</given-names></name><name><surname>Harper</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation</article-title><source>Nature</source><volume>534</volume><fpage>710</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1038/nature18302</pub-id><pub-id pub-id-type="pmid">27350246</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname> <given-names>BJ</given-names></name><name><surname>Klusch</surname> <given-names>N</given-names></name><name><surname>Langer</surname> <given-names>J</given-names></name><name><surname>Mills</surname> <given-names>DJ</given-names></name><name><surname>Yildiz</surname> <given-names>Ö</given-names></name><name><surname>Kühlbrandt</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Rotary substates of mitochondrial ATP synthase reveal the basis of flexible F<sub>1</sub>-F<sub>0</sub> coupling</article-title><source>Science</source><volume>364</volume><elocation-id>eaaw9128</elocation-id><pub-id pub-id-type="doi">10.1126/science.aaw9128</pub-id><pub-id pub-id-type="pmid">31221832</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname> <given-names>T</given-names></name><name><surname>Shimizu</surname> <given-names>S</given-names></name><name><surname>Watanabe</surname> <given-names>T</given-names></name><name><surname>Yamaguchi</surname> <given-names>O</given-names></name><name><surname>Otsu</surname> <given-names>K</given-names></name><name><surname>Yamagata</surname> <given-names>H</given-names></name><name><surname>Inohara</surname> <given-names>H</given-names></name><name><surname>Kubo</surname> <given-names>T</given-names></name><name><surname>Tsujimoto</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death</article-title><source>Nature</source><volume>434</volume><fpage>652</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1038/nature03317</pub-id><pub-id pub-id-type="pmid">15800626</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naresh</surname> <given-names>NU</given-names></name><name><surname>Haynes</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Signaling and regulation of the mitochondrial unfolded protein response</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>11</volume><elocation-id>a033944</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a033944</pub-id><pub-id pub-id-type="pmid">30617048</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nargund</surname> <given-names>AM</given-names></name><name><surname>Pellegrino</surname> <given-names>MW</given-names></name><name><surname>Fiorese</surname> <given-names>CJ</given-names></name><name><surname>Baker</surname> <given-names>BM</given-names></name><name><surname>Haynes</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation</article-title><source>Science</source><volume>337</volume><fpage>587</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1126/science.1223560</pub-id><pub-id pub-id-type="pmid">22700657</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neginskaya</surname> <given-names>MA</given-names></name><name><surname>Solesio</surname> <given-names>ME</given-names></name><name><surname>Berezhnaya</surname> <given-names>EV</given-names></name><name><surname>Amodeo</surname> <given-names>GF</given-names></name><name><surname>Mnatsakanyan</surname> <given-names>N</given-names></name><name><surname>Jonas</surname> <given-names>EA</given-names></name><name><surname>Pavlov</surname> <given-names>EV</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>ATP synthase C-Subunit-Deficient mitochondria have a small cyclosporine A-Sensitive channel, but lack the permeability transition pore</article-title><source>Cell Reports</source><volume>26</volume><fpage>11</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.12.033</pub-id><pub-id pub-id-type="pmid">30605668</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolli</surname> <given-names>A</given-names></name><name><surname>Basso</surname> <given-names>E</given-names></name><name><surname>Petronilli</surname> <given-names>V</given-names></name><name><surname>Wenger</surname> <given-names>RM</given-names></name><name><surname>Bernardi</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, and cyclosporin A-sensitive channel</article-title><source>Journal of Biological Chemistry</source><volume>271</volume><fpage>2185</fpage><lpage>2192</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.4.2185</pub-id><pub-id pub-id-type="pmid">8567677</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname> <given-names>SB</given-names></name><name><surname>Samangouei</surname> <given-names>P</given-names></name><name><surname>Kalkhoran</surname> <given-names>SB</given-names></name><name><surname>Hausenloy</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>78</volume><fpage>23</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2014.11.005</pub-id><pub-id pub-id-type="pmid">25446182</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panel</surname> <given-names>M</given-names></name><name><surname>Ghaleh</surname> <given-names>B</given-names></name><name><surname>Morin</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mitochondria and aging: A role for the mitochondrial transition pore?</article-title><source>Aging Cell</source><volume>17</volume><elocation-id>e12793</elocation-id><pub-id pub-id-type="doi">10.1111/acel.12793</pub-id><pub-id pub-id-type="pmid">29888494</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez</surname> <given-names>MJ</given-names></name><name><surname>Ponce</surname> <given-names>DP</given-names></name><name><surname>Aranguiz</surname> <given-names>A</given-names></name><name><surname>Behrens</surname> <given-names>MI</given-names></name><name><surname>Quintanilla</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mitochondrial permeability transition pore contributes to mitochondrial dysfunction in fibroblasts of patients with sporadic Alzheimer's disease</article-title><source>Redox Biology</source><volume>19</volume><fpage>290</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2018.09.001</pub-id><pub-id pub-id-type="pmid">30199818</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname> <given-names>KV</given-names></name><name><surname>Norenberg</surname> <given-names>MD</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Manganese induces the mitochondrial permeability transition in cultured astrocytes</article-title><source>Journal of Biological Chemistry</source><volume>279</volume><fpage>32333</fpage><lpage>32338</lpage><pub-id pub-id-type="doi">10.1074/jbc.M402096200</pub-id><pub-id pub-id-type="pmid">15173181</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rea</surname> <given-names>SL</given-names></name><name><surname>Ventura</surname> <given-names>N</given-names></name><name><surname>Johnson</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Relationship between mitochondrial electron transport chain dysfunction, development, and life extension in Caenorhabditis elegans</article-title><source>PLOS Biology</source><volume>5</volume><elocation-id>e259</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0050259</pub-id><pub-id pub-id-type="pmid">17914900</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolland</surname> <given-names>SG</given-names></name><name><surname>Schneid</surname> <given-names>S</given-names></name><name><surname>Schwarz</surname> <given-names>M</given-names></name><name><surname>Rackles</surname> <given-names>E</given-names></name><name><surname>Fischer</surname> <given-names>C</given-names></name><name><surname>Haeussler</surname> <given-names>S</given-names></name><name><surname>Regmi</surname> <given-names>SG</given-names></name><name><surname>Yeroslaviz</surname> <given-names>A</given-names></name><name><surname>Habermann</surname> <given-names>B</given-names></name><name><surname>Mokranjac</surname> <given-names>D</given-names></name><name><surname>Lambie</surname> <given-names>E</given-names></name><name><surname>Conradt</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Compromised mitochondrial protein import acts as a signal for UPRmt</article-title><source>Cell Reports</source><volume>28</volume><fpage>1659</fpage><lpage>1669</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.07.049</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rottenberg</surname> <given-names>H</given-names></name><name><surname>Hoek</surname> <given-names>JB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The path from mitochondrial ROS to aging runs through the mitochondrial permeability transition pore</article-title><source>Aging Cell</source><volume>16</volume><fpage>943</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1111/acel.12650</pub-id><pub-id pub-id-type="pmid">28758328</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rual</surname> <given-names>JF</given-names></name><name><surname>Ceron</surname> <given-names>J</given-names></name><name><surname>Koreth</surname> <given-names>J</given-names></name><name><surname>Hao</surname> <given-names>T</given-names></name><name><surname>Nicot</surname> <given-names>AS</given-names></name><name><surname>Hirozane-Kishikawa</surname> <given-names>T</given-names></name><name><surname>Vandenhaute</surname> <given-names>J</given-names></name><name><surname>Orkin</surname> <given-names>SH</given-names></name><name><surname>Hill</surname> <given-names>DE</given-names></name><name><surname>van den Heuvel</surname> <given-names>S</given-names></name><name><surname>Vidal</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library</article-title><source>Genome Research</source><volume>14</volume><fpage>2162</fpage><lpage>2168</lpage><pub-id pub-id-type="doi">10.1101/gr.2505604</pub-id><pub-id pub-id-type="pmid">15489339</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname> <given-names>LW</given-names></name><name><surname>Peng</surname> <given-names>Q</given-names></name><name><surname>Dong</surname> <given-names>M</given-names></name><name><surname>Gao</surname> <given-names>K</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>CY</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Histone deacetylase HDA-1 modulates mitochondrial stress response and longevity</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>4639</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-18501-w</pub-id><pub-id pub-id-type="pmid">32934238</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorrentino</surname> <given-names>V</given-names></name><name><surname>Romani</surname> <given-names>M</given-names></name><name><surname>Mouchiroud</surname> <given-names>L</given-names></name><name><surname>Beck</surname> <given-names>JS</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>D'Amico</surname> <given-names>D</given-names></name><name><surname>Moullan</surname> <given-names>N</given-names></name><name><surname>Potenza</surname> <given-names>F</given-names></name><name><surname>Schmid</surname> <given-names>AW</given-names></name><name><surname>Rietsch</surname> <given-names>S</given-names></name><name><surname>Counts</surname> <given-names>SE</given-names></name><name><surname>Auwerx</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity</article-title><source>Nature</source><volume>552</volume><fpage>187</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1038/nature25143</pub-id><pub-id pub-id-type="pmid">29211722</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname> <given-names>N</given-names></name><name><surname>Hayano</surname> <given-names>T</given-names></name><name><surname>Suzuki</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin</article-title><source>Nature</source><volume>337</volume><fpage>473</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1038/337473a0</pub-id><pub-id pub-id-type="pmid">2644542</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname> <given-names>Y</given-names></name><name><surname>Garcia</surname> <given-names>G</given-names></name><name><surname>Bian</surname> <given-names>Q</given-names></name><name><surname>Steffen</surname> <given-names>KK</given-names></name><name><surname>Joe</surname> <given-names>L</given-names></name><name><surname>Wolff</surname> <given-names>S</given-names></name><name><surname>Meyer</surname> <given-names>BJ</given-names></name><name><surname>Dillin</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mitochondrial stress induces chromatin reorganization to promote longevity and UPR(mt)</article-title><source>Cell</source><volume>165</volume><fpage>1197</fpage><lpage>1208</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.04.011</pub-id><pub-id pub-id-type="pmid">27133166</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urbani</surname> <given-names>A</given-names></name><name><surname>Giorgio</surname> <given-names>V</given-names></name><name><surname>Carrer</surname> <given-names>A</given-names></name><name><surname>Franchin</surname> <given-names>C</given-names></name><name><surname>Arrigoni</surname> <given-names>G</given-names></name><name><surname>Jiko</surname> <given-names>C</given-names></name><name><surname>Abe</surname> <given-names>K</given-names></name><name><surname>Maeda</surname> <given-names>S</given-names></name><name><surname>Shinzawa-Itoh</surname> <given-names>K</given-names></name><name><surname>Bogers</surname> <given-names>JFM</given-names></name><name><surname>McMillan</surname> <given-names>DGG</given-names></name><name><surname>Gerle</surname> <given-names>C</given-names></name><name><surname>Szabò</surname> <given-names>I</given-names></name><name><surname>Bernardi</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Purified F-ATP synthase forms a Ca<sup>2+</sup>-dependent high-conductance channel matching the mitochondrial permeability transition pore</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>4341</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-12331-1</pub-id><pub-id pub-id-type="pmid">31554800</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname> <given-names>X</given-names></name><name><surname>Linton</surname> <given-names>JM</given-names></name><name><surname>Schork</surname> <given-names>NJ</given-names></name><name><surname>Buck</surname> <given-names>LB</given-names></name><name><surname>Petrascheck</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A pharmacological network for lifespan extension in Caenorhabditis elegans</article-title><source>Aging Cell</source><volume>13</volume><fpage>206</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1111/acel.12163</pub-id><pub-id pub-id-type="pmid">24134630</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoneda</surname> <given-names>T</given-names></name><name><surname>Benedetti</surname> <given-names>C</given-names></name><name><surname>Urano</surname> <given-names>F</given-names></name><name><surname>Clark</surname> <given-names>SG</given-names></name><name><surname>Harding</surname> <given-names>HP</given-names></name><name><surname>Ron</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Compartment-specific perturbation of protein handling activates genes encoding mitochondrial chaperones</article-title><source>Journal of Cell Science</source><volume>117</volume><fpage>4055</fpage><lpage>4066</lpage><pub-id pub-id-type="doi">10.1242/jcs.01275</pub-id><pub-id pub-id-type="pmid">15280428</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yung</surname> <given-names>HW</given-names></name><name><surname>Colleoni</surname> <given-names>F</given-names></name><name><surname>Dommett</surname> <given-names>E</given-names></name><name><surname>Cindrova-Davies</surname> <given-names>T</given-names></name><name><surname>Kingdom</surname> <given-names>J</given-names></name><name><surname>Murray</surname> <given-names>AJ</given-names></name><name><surname>Burton</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Noncanonical mitochondrial unfolded protein response impairs placental oxidative phosphorylation in early-onset preeclampsia</article-title><source>PNAS</source><volume>116</volume><fpage>18109</fpage><lpage>18118</lpage><pub-id pub-id-type="doi">10.1073/pnas.1907548116</pub-id><pub-id pub-id-type="pmid">31439814</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Peng</surname> <given-names>D</given-names></name><name><surname>Cheng</surname> <given-names>C</given-names></name><name><surname>Zhou</surname> <given-names>W</given-names></name><name><surname>Ju</surname> <given-names>S</given-names></name><name><surname>Wan</surname> <given-names>D</given-names></name><name><surname>Yu</surname> <given-names>Z</given-names></name><name><surname>Shi</surname> <given-names>J</given-names></name><name><surname>Deng</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>F</given-names></name><name><surname>Ye</surname> <given-names>X</given-names></name><name><surname>Hu</surname> <given-names>Z</given-names></name><name><surname>Lin</surname> <given-names>J</given-names></name><name><surname>Ruan</surname> <given-names>L</given-names></name><name><surname>Sun</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Bacillus thuringiensis crystal protein Cry6Aa triggers Caenorhabditis elegans necrosis pathway mediated by aspartic protease (ASP-1)</article-title><source>PLOS Pathogens</source><volume>12</volume><elocation-id>e1005389</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005389</pub-id><pub-id pub-id-type="pmid">26795495</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Chen</surname> <given-names>P</given-names></name><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>Xin</surname> <given-names>N</given-names></name><name><surname>Tian</surname> <given-names>Y</given-names></name><name><surname>Dillin</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The mitochondrial unfolded protein response is mediated Cell-Non-autonomously by Retromer-Dependent wnt signaling</article-title><source>Cell</source><volume>174</volume><fpage>870</fpage><lpage>883</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.06.029</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>J</given-names></name><name><surname>Ramirez</surname> <given-names>VD</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Purification and identification of an estrogen binding protein from rat brain: oligomycin sensitivity-conferring protein (OSCP), a subunit of mitochondrial F0F1-ATP synthase/ATPase</article-title><source>The Journal of Steroid Biochemistry and Molecular Biology</source><volume>68</volume><fpage>65</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/S0960-0760(98)00161-7</pub-id><pub-id pub-id-type="pmid">10215039</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>D</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Zhou</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Huang</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Bian</surname> <given-names>Q</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Tian</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>NuRD mediates mitochondrial stress-induced longevity via chromatin remodeling in response to acetyl-CoA level</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eabb2529</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abb2529</pub-id><pub-id pub-id-type="pmid">32789178</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63453.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Lee</surname><given-names>Siu Sylvia</given-names></name><role>Reviewing Editor</role><aff><institution>Cornell University</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>Both reviewers found the manuscript to be of high impact to the field. Particularly intriguing is the finding that disruption of a complex V component activates the mitochondrial unfolded protein response and affects longevity via mechanisms that appear distinct from disruptions of the other complexes, as previously reported.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;The mitochondrial permeability transition pore activates a maladaptive mitochondrial unfolded protein response&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Jessica Tyler as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>The authors provided evidence to suggest that RNAi knockdown of the mitochondrial ATP synthase subunit atp-3 in adults triggers mitochondrial permeability transition pore (mPTP), resulting in activation of the mitochondrial unfolded protein response (UPRmt) and shortening of lifespan. This is particularly intriguing as this observation in adult animals contradicts the well-established findings in the field that RNAi of various mitochondrial electron transport chain subunits, including atp-3, during development leads to a transient activation of the UPRmt during larval but not adult stage, and extension of adult lifespan. Further investigation into UPRmt during development vs in adulthood will be important for understanding this important pathway in aging. This study will also contribute to helping clarify the controversial field of mPTP.</p><p>Essential revisions:</p><p>The reviewers appreciated the potential importance of this work, but more evidence are needed to support the major claims put forth.</p><p>A) Additional experimental evidence are required to demonstrate that atp-3 RNAi indeed induces mPTP.</p><p>1. The authors stated at the beginning of the manuscript that the opening of the mPTP is characterized by a loss of mitochondrial membrane potential and an increase in cytosolic ca<sup>2+</sup>, however, the measurements of the membrane potential and the cytosolic ca<sup>2+</sup> levels were missing from many key experiments. For example, in figure S2, the authors showed that the activation of the pdvUPRmt is reversible, however, whether the loss of membrane potential and the increase in cytosolic ca<sup>2+</sup> were also reversed was not shown. The same measurement should also apply to the situation when the pdvUPRmt induced by atp-3 RNAi was suppressed by the RNAi against the ATPases subunits (a and b), the two UPRmt regulators (haf-1(the mitochondrial protein), atfs<sup>-1</sup>(the downstream TF), or by the pharmacological inhibitors mPTP, and in the long-lived mutants (daf-2, glp-1)).</p><p>2. Along with the previous point, the authors showed that loss of FCCP, a mitochondrial uncoupler, did not induce a UPRmt in adults, therefore excluding the possibility that loss of mitochondrial membrane potential is not sufficient to induce pdvUPRmt. However, it has been shown that FCCP treatment induces the UPRmt in mammalian cells (Fessler et al., 2020). Therefore, controls with measurement of the mitochondrial membrane potential and the ca<sup>2+</sup> measurement after FCCP treatments should be included to demonstrate the efficiency of the drug treatment.</p><p>3. It is also difficult to understand the phenotypical differences between RNAi of atp-1 and atp-3. Loss of atp-1 and atp-3 can both induce the pdvUPRmt, however, atp-1 RNAi had no effect on the membrane potential but could partially suppress the pdvUPRmt induced by atp-3 RNAi.</p><p>The reviewers pointed out papers in the literature that argued against the proposal that the mPTP is associated with the ATP synthase. Given that this is a controversial topic, clear evidence must be provided to convince the readers otherwise.</p><p>B) Epistasis analysis between dvUPRmt and pdvUPRmt will be key to understand the interesting opposing observations.</p><p>1) Mechanistically, why the inductions of dvUPRmt and pdvUPRmt have such huge differences in the regulation of organismal aging? The authors have not excluded the possibility that the mPTP is not formed when dvUPRmt is induced.</p><p>2) Inhibition of multiple OXPHOS components such as CCO-1 during development activates UPRmt and extends worm lifespan. However, inhibition of CCO-1 at or after the L4 stage does not activate UPRmt or extend lifespan. Here, the authors demonstrate that inhibition of atp-3/OSCP during development activates the UPRmt and extends lifespan. However, inhibition of atp-3/OSCP at the young adult stage also activates the UPRmt, but shortens lifespan. Which is dominant? Is cco-1(RNAi)-dependent lifespan extension suppressed by atp-3(RNAi) administered at the young adult stage?</p><p>This line of investigation is necessary to provide a clearer picture about how activation of UPRmt influences aging.</p><p>C) The data on genetic interactions with other longevity mutants appear premature. The reviewers suggested completely removing that part from this manuscript, so that the current manuscript can focus on A and B above.</p><p>– The section titled &quot;Longevity mutants display exceptional mitochondria partially via FOXO/daf-16&quot; is intriguing but much too underdeveloped. I agree that it is interesting that several longevity mutants suppress the post-developmental UPRmt.</p><p>– However, the subsequent claims about &quot;exceptional mitochondria&quot; and increased mitochondrial mass using mtGFP as a marker are not convincing. For example, the ges<sup>-1</sup> promoter is induced by DAF-16, confounding the results. Mitochondriall staining independent of mtGFP should be performed such as TMRE. The imaging should also be of higher magnification. mtDNA quantification should be provided as an imaging-independent indicator of mitochondrial mass. The authors should also determine if the &quot;exceptional mitochondria&quot; in these worms provide more mitochondrial activity by measuring oxygen consumption etc. The data suggesting that mitophagy contributes to the loss of mitochondrial mass are also underdeveloped. Images should be provided and mitochondrial mass should be quantified via a mtGFP independent mechanism. I would suggest simply removing this section as it largely detracts from the rest of the manuscript.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63453.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>The reviewers appreciated the potential importance of this work, but more evidence are needed to support the major claims put forth.</p><p>A) Additional experimental evidence are required to demonstrate that atp-3 RNAi indeed induces mPTP.</p></disp-quote><p>To address this critique, we decided to use the well characterized mPTP inhibitior, cylosporin A (CsA), to determine if it could reverse the mPTP characteristics caused by adult loss of OSCP<italic>/atp-3.</italic> The use of CsA is an established method to help confirm the identity of the mPTP in many models, such as isolated mitoblasts and cell lines. We found that CsA was able to reverse all mPTP-like characteristics due to adult loss of OSCP/<italic>atp-3</italic>, which included loss of MMP, rise in cytosolioc ca<sup>2+</sup>, lifespan shortening, and mitochondrial rounding/fragmentation (Figures 1C, 1F, 1I, 1J, 3G). These finding significantly strengthen our claim that our observations are due to the mPTP.</p><p>To additionally address this critique, we further examined our epistasis experiments that showed that the pdvUPR<sup>mt</sup> can be suppressed due to loss of additional F-ATP synthase subunits. Epistatic experiments also reverse nearly all mPTP-like characteristics due to adult loss of OSCP/<italic>atp-3</italic>, which include loss of MMP, rise in cytosolioc ca<sup>2+</sup>, lifespan shortening, and mitochondrial rounding/fragmentation (Figure 6). These finding support a model in which F-ATP synthase, especially the proton-driving c-ring rotor, is likely to form the mPTP.</p><disp-quote content-type="editor-comment"><p>1. The authors stated at the beginning of the manuscript that the opening of the mPTP is characterized by a loss of mitochondrial membrane potential and an increase in cytosolic ca<sup>2+</sup>, however, the measurements of the membrane potential and the cytosolic ca<sup>2+</sup> levels were missing from many key experiments. For example, in figure S2, the authors showed that the activation of the pdvUPRmt is reversible, however，whether the loss of membrane potential and the increase in cytosolic ca<sup>2+</sup> were also reversed was not shown. The same measurement should also apply to the situation when the pdvUPRmt induced by atp-3 RNAi was suppressed by the RNAi against the ATPases subunits (a and b), the two UPRmt regulators (haf-1(the mitochondrial protein), atfs<sup>-1</sup>(the downstream TF), or by the pharmacological inhibitors mPTP, and in the long-lived mutants (daf-2, glp-1)).</p><p>2. Along with the previous point, the authors showed that loss of FCCP, a mitochondrial uncoupler, did not induce a UPRmt in adults, therefore excluding the possibility that loss of mitochondrial membrane potential is not sufficient to induce pdvUPRmt. However, it has been shown that FCCP treatment induces the UPRmt in mammalian cells (Fessler et al., 2020). Therefore, controls with measurement of the mitochondrial membrane potential and the ca<sup>2+</sup> measurement after FCCP treatments should be included to demonstrate the efficiency of the drug treatment.</p></disp-quote><p>We verified that FCCP did induce a loss of MMP during adulthood, demonstrating the drug efficacy, while also failing to increase cytosolic ca<sup>2+</sup> levels (Figure 1—figure supplement 1A, B), demonstrating that loss of MMP per se is not sufficient to recapitulate the mPTP.</p><disp-quote content-type="editor-comment"><p>3. It is also difficult to understand the phenotypical differences between RNAi of atp-1 and atp-3. Loss of atp-1 and atp-3 can both induce the pdvUPRmt, however, atp-1 RNAi had no effect on the membrane potential but could partially suppress the pdvUPRmt induced by atp-3 RNAi.</p></disp-quote><p>We further tested the role of the a/<italic>atp-1</italic> subunit. In addition to its loss not inducing a loss of MMP, its loss also did not lead to a rise in cytosolic ca<sup>2+</sup> (Figure 1E) and had minor effects on lifespan (Figure 4F). Thus, its ability to induce a moderately robust pdvUPR<sup>mt</sup> does not necessitate that it display mPTP characteristics. We conclude from these findings that mPTP activation is very specific to the loss of OSCP/<italic>atp-3</italic>.</p><disp-quote content-type="editor-comment"><p>The reviewers pointed out papers in the literature that argued against the proposal that the mPTP is associated with the ATP synthase. Given that this is a controversial topic, clear evidence must be provided to convince the readers otherwise.</p></disp-quote><p>We added more context in the introduction that references that experts in the field of the mPTP largely consider F-ATP synthase to be the probable pore-forming component. This is not without dispute though, as we also further discuss in the introduction. Thus, while our findings do not conclusively ascertain that the F-ATP synthase is the mPTP, they are supportive of the prevailing F-ATP synthase models of the mPTP.</p><disp-quote content-type="editor-comment"><p>B) Epistasis analysis between dvUPRmt and pdvUPRmt will be key to understand the interesting opposing observations.1) Mechanistically, why the inductions of dvUPRmt and pdvUPRmt have such huge differences in the regulation of organismal aging? The authors have not excluded the possibility that the mPTP is not formed when dvUPRmt is induced.</p></disp-quote><p>We performed additional experiments analysing cytosolic ca<sup>2+</sup> release and found that loss of OSCP/<italic>atp-3</italic> during development does not lead to a release of cytosolic ca<sup>2+</sup> (Figure 1—figure supplement 1D), a canonical feature of the mPTP. This finding, in addition to our previous findings that the dvUPR<sup>mt</sup> is not responsive to CsA or genetic mPTP factors (Figure 3A, B), lead us to conclude that the dvUPR<sup>mt</sup> is not likely coupled to the mPTP.</p><disp-quote content-type="editor-comment"><p>2) Inhibition of multiple OXPHOS components such as CCO-1 during development activates UPRmt and extends worm lifespan. However, inhibition of CCO-1 at or after the L4 stage does not activate UPRmt or extend lifespan. Here, the authors demonstrate that inhibition of atp-3/OSCP during development activates the UPRmt and extends lifespan. However, inhibition of atp-3/OSCP at the young adult stage also activates the UPRmt, but shortens lifespan. Which is dominant? Is cco-1(RNAi)-dependent lifespan extension suppressed by atp-3(RNAi) administered at the young adult stage?</p><p>This line of investigation is necessary to provide a clearer picture about how activation of UPRmt influences aging.</p></disp-quote><p>This interesting experiment proposed by the reviewers led to an interesting result. We found that developmental treatment with COX5B/<italic>cco-1</italic> RNAi followed by post-developmental treatment with OSCP/<italic>atp-3</italic> RNAi did not significantly alter the long-lived phenotype cause by developmental <italic>cco-1</italic>, suggesting that the <italic>cco-1</italic> regulation of longevity is “dominant”. We agree further investigation into how the dvUPR<sup>mt</sup> and the pdvUPR<sup>mt</sup> are regulated is an area of high priority for future studies.</p><disp-quote content-type="editor-comment"><p>C) The data on genetic interactions with other longevity mutants appear premature. The reviewers suggested completely removing that part from this manuscript, so that the current manuscript can focus on A and B above.</p></disp-quote><p>We agree and have accordingly removed this portion.</p></body></sub-article></article>